Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Lloyd Old

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Disorders

Anatomy

Concepts & Ideas

Molecular Sequence Data

Genes & Molecular Sequences

Amino Acid Sequence

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Janetzki Sylvia; Britten Cedrik M; Kalos Michael; Levitsky Hyam I; Maecker Holden T; Melief Cornelius J M; Old Lloyd J; Romero Pedro; Hoos Axel; Davis Mark M
"MIATA"-minimal information about T cell assays.
Tsuji Takemasa; Altorki Nasser K; Ritter Gerd; Old Lloyd J; Gnjatic Sacha
Characterization of preexisting MAGE-A3-specific CD4+ T cells in cancer patients and healthy individuals and their activation by protein vaccination.
da Cunha J P C; Galante P A F; de Souza J E; de Souza R F; Carvalho P M; Ohara D T; Moura R P; Oba-Shinja S M; Marie S K N; Silva W A; Perez R O; Stransky B; Pieprzyk M; Moore J; Caballero O; Gama-Rodrigues J; Habr-Gama A; Kuo W P; Simpson A J; Camargo A A; Old Lloyd J; de Souza S J
Bioinformatics construction of the human cell surfaceome.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Lloyd Old (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Janetzki Sylvia; Britten Cedrik M; Kalos Michael; Levitsky Hyam I; Maecker Holden T; Melief Cornelius J M; Old Lloyd J; Romero Pedro; Hoos Axel; Davis Mark M
"MIATA"-minimal information about T cell assays.
Immunity 2009;31(4):527-8.
2009: Tsuji Takemasa; Altorki Nasser K; Ritter Gerd; Old Lloyd J; Gnjatic Sacha
Characterization of preexisting MAGE-A3-specific CD4+ T cells in cancer patients and healthy individuals and their activation by protein vaccination.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(7):4800-8.
2009: da Cunha J P C; Galante P A F; de Souza J E; de Souza R F; Carvalho P M; Ohara D T; Moura R P; Oba-Shinja S M; Marie S K N; Silva W A; Perez R O; Stransky B; Pieprzyk M; Moore J; Caballero O; Gama-Rodrigues J; Habr-Gama A; Kuo W P; Simpson A J; Camargo A A; Old Lloyd J; de Souza S J
Bioinformatics construction of the human cell surfaceome.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(39):16752-7.
2009: Grigoriadis Anita; Caballero Otavia L; Hoek Keith S; da Silva Leonard; Chen Yao-Tseng; Shin Sandra J; Jungbluth Achim A; Miller Lance D; Clouston David; Cebon Jonathan; Old Lloyd J; Lakhani Sunil R; Simpson Andrew J G; Neville A Munro
CT-X antigen expression in human breast cancer.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(32):13493-8.
2009: Bioley Gilles; Dousset Christelle; Yeh Alice; Dupont Bo; Bhardwaj Nina; Mears Gregory; Old Lloyd J; Ayyoub Maha; Valmori Danila
Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(13):4467-74.
2009: Qian Feng; Villella Jeannine; Wallace Paul K; Mhawech-Fauceglia Paulette; Tario Joseph D; Andrews Christopher; Matsuzaki Junko; Valmori Danila; Ayyoub Maha; Frederick Peter J; Beck Amy; Liao Jianqun; Cheney Richard; Moysich Kirsten; Lele Shashikant; Shrikant Protul; Old Lloyd J; Odunsi Kunle
Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer.
Cancer research 2009;69(13):5498-504.
2009: Bauer Stefan; Oosterwijk-Wakka Jeannette C; Adrian Nicole; Oosterwijk Egbert; Fischer Eliane; Wüest Thomas; Stenner Frank; Perani Angelo; Cohen Leonard; Knuth Alexander; Divgi Chaitanya; Jäger Dirk; Scott Andrew M; Ritter Gerd; Old Lloyd J; Renner Christoph
Targeted therapy of renal cell carcinoma: synergistic activity of cG250-TNF and IFNg.
International journal of cancer. Journal international du cancer 2009;125(1):115-23.
2009: Chen Yao-Tseng; Hsu Melinda; Lee Peishan; Shin Sandra J; Mhawech-Fauceglia Paulette; Odunsi Kunle; Altorki Nasser K; Song Chao-Jun; Jin Bo-Quan; Simpson Andrew J; Old Lloyd J
Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer.
International journal of cancer. Journal international du cancer 2009;124(12):2893-8.
2009: Garrett Thomas P J; Burgess Antony W; Gan Hui K; Luwor Rod B; Cartwright Glenn; Walker Francesca; Orchard Suzanne G; Clayton Andrew H A; Nice Edouard C; Rothacker Julie; Catimel Bruno; Cavenee Webster K; Old Lloyd J; Stockert Elisabeth; Ritter Gerd; Adams Timothy E; Hoyne Peter A; Wittrup Dane; Chao Ginger; Cochran Jennifer R; Luo Cindy; Lou Mezhen; Huyton Trevor; Xu Yibin; Fairlie W Douglas; Yao Shenggen; Scott Andrew M; Johns Terrance G
Antibodies specifically targeting a locally misfolded region of tumor associated EGFR.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(13):5082-7.
2009: Gnjatic Sacha; Altorki Nasser K; Tang Derek Ng; Tu Shi-Ming; Kundra Vikas; Ritter Gerd; Old Lloyd J; Logothetis Christopher J; Sharma Padmanee
NY-ESO-1 DNA vaccine induces T-cell responses that are suppressed by regulatory T cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(6):2130-9.
2009: Leveque Lucie; Deknuydt Florence; Bioley Gilles; Old Lloyd J; Matsuzaki Junko; Odunsi Kunle; Ayyoub Maha; Valmori Danila
Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(2):101-8.
2009: Gnjatic Sacha; Wheeler Colin; Ebner Martin; Ritter Erika; Murray Anne; Altorki Nasser K; Ferrara Cathy A; Hepburne-Scott Henry; Joyce Sarah; Koopman Jens; McAndrew Michael B; Workman Nicholas; Ritter Gerd; Fallon Rachel; Old Lloyd J
Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays.
Journal of immunological methods 2009;341(1-2):50-8.
2009: Bioley Gilles; Guillaume Philippe; Luescher Immanuel; Yeh Alice; Dupont Bo; Bhardwaj Nina; Mears Gregory; Old Lloyd J; Valmori Danila; Ayyoub Maha
HLA class I - associated immunodominance affects CTL responsiveness to an ESO recombinant protein tumor antigen vaccine.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(1):299-306.
2009: Lin Yun; Gallardo Humilidad F; Ku Geoffrey Y; Li Hao; Manukian Gregor; Rasalan Teresa S; Xu Yinyan; Terzulli Stephanie L; Old Lloyd J; Allison James P; Houghton Alan N; Wolchok Jedd D; Yuan Jianda
Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses.
Cytotherapy 2009;11(7):912-22.
2009: Tchabo Nana E; Mhawech-Fauceglia Paulette; Caballero Otavia L; Villella Jeannine; Beck Amy F; Miliotto Anthony J; Liao Jianqun; Andrews Christopher; Lele Shashikant; Old Lloyd J; Odunsi Kunle
Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancer.
Cancer immunity : a journal of the Academy of Cancer Immunology 2009;9():6.
2009: Yuan Jianda; Ku Geoffrey Y; Gallardo Humilidad F; Orlandi Francesca; Manukian Gregor; Rasalan Teresa S; Xu Yinyan; Li Hao; Vyas Shachi; Mu Zhenyu; Chapman Paul B; Krown Susan E; Panageas Katherine; Terzulli Stephanie L; Old Lloyd J; Houghton Alan N; Wolchok Jedd D
Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma.
Cancer immunity : a journal of the Academy of Cancer Immunology 2009;9():5.
2009: Gnjatic Sacha; Old Lloyd J; Chen Yao-Tseng
Autoantibodies against cancer antigens.
Methods in molecular biology (Clifton, N.J.) 2009;520():11-9.
2009: Bauer Stefan; Adrian Nicole; Siebenborn Uta; Fadle Natalie; Plesko Margarita; Fischer Eliane; Wüest Thomas; Stenner Frank; Mertens Joachim C; Knuth Alexander; Ritter Gerd; Old Lloyd J; Renner Christoph
Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8.
Cancer immunity : a journal of the Academy of Cancer Immunology 2009;9():2.
2008: Eck Wolfgang; Craig Gary; Sigdel Aruna; Ritter Gerd; Old Lloyd J; Tang Laura; Brennan Murray F; Allen Peter J; Mason Michael D
PEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted labeling agents for human pancreatic carcinoma tissue.
ACS nano 2008;2(11):2263-72.
2008: Sharma Padmanee; Bajorin Dean F; Jungbluth Achim A; Herr Harry; Old Lloyd J; Gnjatic Sacha
Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSF.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(9):849-57.
2008: Wada Hisashi; Sato Eiichi; Uenaka Akiko; Isobe Midori; Kawabata Ryohei; Nakamura Yurika; Iwae Shigemichi; Yonezawa Kouichiro; Yamasaki Makoto; Miyata Hiroshi; Doki Yuichiro; Shiku Hiroshi; Jungbluth Achim A; Ritter Gerd; Murphy Roger; Hoffman Eric W; Old Lloyd J; Monden Morito; Nakayama Eiichi
Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination.
International journal of cancer. Journal international du cancer 2008;123(10):2362-9.
2008: Tsuji Kazuhide; Hamada Toshitada; Uenaka Akiko; Wada Hisashi; Sato Eiichi; Isobe Midori; Asagoe Kenji; Yamasaki Osamu; Shiku Hiroshi; Ritter Gerd; Murphy Roger; Hoffman Eric W; Old Lloyd J; Nakayama Eiichi; Iwatsuki Keiji
Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient.
Cancer immunology, immunotherapy : CII 2008;57(10):1429-37.
2008: Howland Shanshan W; Tsuji Takemasa; Gnjatic Sacha; Ritter Gerd; Old Lloyd J; Wittrup Karl Dane
Inducing efficient cross-priming using antigen-coated yeast particles.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(7):607-19.
2008: Matsuzaki Junko; Qian Feng; Luescher Immanuel; Lele Shashikant; Ritter Gerd; Shrikant Protul A; Gnjatic Sacha; Old Lloyd J; Odunsi Kunle
Recognition of naturally processed and ovarian cancer reactive CD8+ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1.
Cancer immunology, immunotherapy : CII 2008;57(8):1185-95.
2008: Nishikawa Hiroyoshi; Kato Takuma; Hirayama Michiko; Orito Yuki; Sato Eiichi; Harada Naozumi; Gnjatic Sacha; Old Lloyd J; Shiku Hiroshi
Regulatory T cell-resistant CD8+ T cells induced by glucocorticoid-induced tumor necrosis factor receptor signaling.
Cancer research 2008;68(14):5948-54.
2008: Ackerman Margaret E; Chalouni Cecile; Schmidt Michael M; Raman Vivek V; Ritter Gerd; Old Lloyd J; Mellman Ira; Wittrup K Dane
A33 antigen displays persistent surface expression.
Cancer immunology, immunotherapy : CII 2008;57(7):1017-27.
2008: Diefenbach Catherine S M; Gnjatic Sacha; Sabbatini Paul; Aghajanian Carol; Hensley Martee L; Spriggs David R; Iasonos Alexia; Lee Helen; Dupont Bo; Pezzulli Sandra; Jungbluth Achim A; Old Lloyd J; Dupont Jakob
Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(9):2740-8.
2008: Smith-Jones Peter M; Pandit-Taskar Neeta; Cao Wei; O'Donoghue Joseph; Philips Martin D; Carrasquillo Jorge; Konner Jason A; Old Lloyd J; Larson Steven M
Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003.
Nuclear medicine and biology 2008;35(3):343-51.
2008: Oosterwijk Egbert; Boerman Otto C; Oyen Wim J C; Old Lloyd J; Mulders Peter F A
Antibody therapy in renal cell carcinoma.
World journal of urology 2008;26(2):141-6.
2008: Shao Yi; Sun Zhen-Yuan; Sun Shi-Wei; Zhao Yi; Sin Wan Yee; Yuan Yan-Hua; Simpson Andrew J; Old Lloyd J; Sang Xin-Ting; Mao Yi-Lei; Xie Yong; Huang Jie-Fu; Zhao Hai-Tao
Identification and expression analysis of novel LAGE-1 alleles with single nucleotide polymorphisms in cancer patients.
Journal of cancer research and clinical oncology 2008;134(4):495-502.
2008: Tosello Valeria; Odunsi Kunle; Souleimanian Naira E; Lele Shashikant; Shrikant Protul; Old Lloyd J; Valmori Danila; Ayyoub Maha
Differential expression of CCR7 defines two distinct subsets of human memory CD4+CD25+ Tregs.
Clinical immunology (Orlando, Fla.) 2008;126(3):291-302.
2008: Kageyama Shinichi; Kitano Shigehisa; Hirayama Michiko; Nagata Yasuhiro; Imai Hiroshi; Shiraishi Taizo; Akiyoshi Kazunari; Scott Andrew M; Murphy Roger; Hoffman Eric W; Old Lloyd J; Katayama Naoyuki; Shiku Hiroshi
Humoral immune responses in patients vaccinated with 1-146 HER2 protein complexed with cholesteryl pullulan nanogel.
Cancer science 2008;99(3):601-7.
2008: Atanackovic Djordje; Altorki Nasser K; Cao Yanran; Ritter Erika; Ferrara Cathy A; Ritter Gerd; Hoffman Eric W; Bokemeyer Carsten; Old Lloyd J; Gnjatic Sacha
Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(5):1650-5.
2008: Nishikawa Hiroyoshi; Tsuji Takemasa; Jäger Elke; Briones Gabriel; Ritter Gerd; Old Lloyd J; Galán Jorge E; Shiku Hiroshi; Gnjatic Sacha
Induction of regulatory T cell-resistant helper CD4+ T cells by bacterial vector.
Blood 2008;111(3):1404-12.
2008: Ishida Toshiaki; Obata Yuichi; Ohara Nobuya; Matsushita Hirokazu; Sato Shuichiro; Uenaka Akiko; Saika Takashi; Miyamura Takako; Chayama Kosuke; Nakamura Yurika; Wada Hisashi; Yamashita Toshiharu; Morishima Tsuneo; Old Lloyd J; Nakayama Eiichi
Identification of the HERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicity.
Cancer immunity : a journal of the Academy of Cancer Immunology 2008;8():15.
2008: Oba-Shinjo Sueli M; Caballero Otavia L; Jungbluth Achim A; Rosemberg Sergio; Old Lloyd J; Simpson Andrew J G; Marie Suely K N
Cancer-testis (CT) antigen expression in medulloblastoma.
Cancer immunity : a journal of the Academy of Cancer Immunology 2008;8():7.
2008: Old Lloyd J
Cancer vaccines: an overview.
Cancer immunity : a journal of the Academy of Cancer Immunology 2008;8 Suppl 1():1.
2008: Yin Beatrice W T; Kiyamova Ramziya; Chua Ramon; Caballero Otavia L; Gout Ivan; Gryshkova Vitalina; Bhaskaran Nimesh; Souchelnytskyi Serhiy; Hellman Ulf; Filonenko Valeriy; Jungbluth Achim A; Odunsi Kunle; Lloyd Kenneth O; Old Lloyd J; Ritter Gerd
Monoclonal antibody MX35 detects the membrane transporter NaPi2b (SLC34A2) in human carcinomas.
Cancer immunity : a journal of the Academy of Cancer Immunology 2008;8():3.
2007: Perera Rushika M; Zoncu Roberto; Johns Terrance G; Pypaert Marc; Lee Fook-Thean; Mellman Ira; Old Lloyd J; Toomre Derek K; Scott Andrew M
Internalization, intracellular trafficking, and biodistribution of monoclonal antibody 806: a novel anti-epidermal growth factor receptor antibody.
Neoplasia (New York, N.Y.) 2007;9(12):1099-110.
2007: Kiniwa Yukiko; Miyahara Yoshihiro; Wang Helen Y; Peng Weiyi; Peng Guangyong; Wheeler Thomas M; Thompson Timothy C; Old Lloyd J; Wang Rong-Fu
CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(23):6947-58.
2007: Koebel Catherine M; Vermi William; Swann Jeremy B; Zerafa Nadeen; Rodig Scott J; Old Lloyd J; Smyth Mark J; Schreiber Robert D
Adaptive immunity maintains occult cancer in an equilibrium state.
Nature 2007;450(7171):903-7.
2007: Huang Chung-Jr; Chen Rishard H; Vannelli Todd; Lee Frank; Ritter Erika; Ritter Gerd; Old Lloyd J; Batt Carl A
Expression and purification of the cancer antigen SSX2: a potential cancer vaccine.
Protein expression and purification 2007;56(2):212-9.
2007: Szmania Susann; Gnjatic Sacha; Tricot Guido; Stone Katie; Zhan Fenghuang; Moreno Amberly; Thuro Brad; Melenhorst Jos; Barrett John; Shaughnessy John; Old Lloyd J; Barlogie Bart; Brichard Vincent G; van Rhee Frits
Immunization with a recombinant MAGE-A3 protein after high-dose therapy for myeloma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2007;30(8):847-54.
2007: Karbach Julia; Gnjatic Sacha; Pauligk Claudia; Bender Armin; Maeurer Markus; Schultze Joachim L; Nadler Kerstin; Wahle Claudia; Knuth Alexander; Old Lloyd J; Jäger Elke
Tumor-reactive CD8+ T-cell clones in patients after NY-ESO-1 peptide vaccination.
International journal of cancer. Journal international du cancer 2007;121(9):2042-8.
2007: Krug Lee M; Milton Daniel T; Jungbluth Achim A; Chen Lin-Chi; Quaia Emilio; Pandit-Taskar Neeta; Nagel Andrew; Jones Jessica; Kris Mark G; Finn Ronald; Smith-Jones Peter; Scott Andrew M; Old Lloyd; Divgi Chaitanya
Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: a pilot trial testing two dose levels.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(10):947-52.
2007: Odunsi Kunle; Qian Feng; Matsuzaki Junko; Mhawech-Fauceglia Paulette; Andrews Christopher; Hoffman Eric W; Pan Linda; Ritter Gerd; Villella Jeannine; Thomas Bridget; Rodabaugh Kerry; Lele Shashikant; Shrikant Protul; Old Lloyd J; Gnjatic Sacha
Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(31):12837-42.
2007: Scott Andrew M; Tebbutt Niall; Lee Fook-Thean; Cavicchiolo Tina; Liu Zhanqi; Gill Sanjeev; Poon Aurora M T; Hopkins Wendie; Smyth Fiona E; Murone Carmel; MacGregor Duncan; Papenfuss Anthony T; Chappell Bridget; Saunder Timothy H; Brechbiel Martin W; Davis Ian D; Murphy Roger; Chong Geoffrey; Hoffman Eric W; Old Lloyd J
A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(11):3286-92.
2007: Valmori Danila; Souleimanian Naira E; Tosello Valeria; Bhardwaj Nina; Adams Sylvia; O'Neill David; Pavlick Anna; Escalon Juliet B; Cruz Crystal M; Angiulli Angelica; Angiulli Francesca; Mears Gregory; Vogel Susan M; Pan Linda; Jungbluth Achim A; Hoffmann Eric W; Venhaus Ralph; Ritter Gerd; Old Lloyd J; Ayyoub Maha
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(21):8947-52.
2007: Kawabata Ryohei; Wada Hisashi; Isobe Midori; Saika Takashi; Sato Shuichiro; Uenaka Akiko; Miyata Hiroshi; Yasuda Takushi; Doki Yuichiro; Noguchi Yuji; Kumon Hiromi; Tsuji Kazuhide; Iwatsuki Keiji; Shiku Hiroshi; Ritter Gerd; Murphy Roger; Hoffman Eric; Old Lloyd J; Monden Morito; Nakayama Eiichi
Antibody response against NY-ESO-1 in CHP-NY-ESO-1 vaccinated patients.
International journal of cancer. Journal international du cancer 2007;120(10):2178-84.
2007: Divgi Chaitanya R; Pandit-Taskar Neeta; Jungbluth Achim A; Reuter Victor E; Gönen Mithat; Ruan Shutian; Pierre Christine; Nagel Andrew; Pryma Daniel A; Humm John; Larson Steven M; Old Lloyd J; Russo Paul
Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial.
The lancet oncology 2007;8(4):304-10.
2007: Sharma Padmanee; Old Lloyd J; Allison James P
Immunotherapeutic strategies for high-risk bladder cancer.
Seminars in oncology 2007;34(2):165-72.
2007: Jäger Dirk; Filonenko Valeriy; Gout Ivan; Frosina Denise; Eastlake-Wade Susannah; Castelli Sandra; Varga Zsuzsanna; Moch Holger; Chen Yao-Tseng; Busam Klaus J; Seil Inka; Old Lloyd J; Nissan Aviram; Frei Claudia; Gure Ali O; Knuth Alexander; Jungbluth Achim A
NY-BR-1 is a differentiation antigen of the mammary gland.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2007;15(1):77-83.
2007: Scott Andrew M; Lee Fook-Thean; Tebbutt Niall; Herbertson Rebecca; Gill Sanjeev S; Liu Zhanqi; Skrinos Effie; Murone Carmel; Saunder Timothy H; Chappell Bridget; Papenfuss Anthony T; Poon Aurora M T; Hopkins Wendie; Smyth Fiona E; MacGregor Duncan; Cher Lawrence M; Jungbluth Achim A; Ritter Gerd; Brechbiel Martin W; Murphy Roger; Burgess Antony W; Hoffman Eric W; Johns Terrance G; Old Lloyd J
A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(10):4071-6.
2007: Sharma Padmanee; Shen Yu; Wen Sijin; Yamada Sachiko; Jungbluth Achim A; Gnjatic Sacha; Bajorin Dean F; Reuter Victor E; Herr Harry; Old Lloyd J; Sato Eiichi
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(10):3967-72.
2007: Li Danan; Ji Hongbin; Zaghlul Sara; McNamara Kate; Liang Mei-Chih; Shimamura Takeshi; Kubo Shigeto; Takahashi Masaya; Chirieac Lucian R; Padera Robert F; Scott Andrew M; Jungbluth Achim A; Cavenee Webster K; Old Lloyd J; Demetri George D; Wong Kwok-Kin
Therapeutic anti-EGFR antibody 806 generates responses in murine de novo EGFR mutant-dependent lung carcinomas.
The Journal of clinical investigation 2007;117(2):346-52.
2007: Valmori Danila; Lévy Frédéric; Godefroy Emmanuelle; Scotto Luigi; Souleimanian Naira E; Karbach Julia; Tosello Valeria; Hesdorffer Charles S; Old Lloyd J; Jager Elke; Ayyoub Maha
Epitope clustering in regions undergoing efficient proteasomal processing defines immunodominant CTL regions of a tumor antigen.
Clinical immunology (Orlando, Fla.) 2007;122(2):163-72.
2007: Damasceno Leonardo M; Anderson Kyle A; Ritter Gerd; Cregg James M; Old Lloyd J; Batt Carl A
Cooverexpression of chaperones for enhanced secretion of a single-chain antibody fragment in Pichia pastoris.
Applied microbiology and biotechnology 2007;74(2):381-9.
2007: Atanackovic Djordje; Arfsten Julia; Cao Yanran; Gnjatic Sacha; Schnieders Frank; Bartels Katrin; Schilling Georgia; Faltz Christiane; Wolschke Christine; Dierlamm Judith; Ritter Gerd; Eiermann Thomas; Hossfeld Dieter Kurt; Zander Axel R; Jungbluth Achim A; Old Lloyd J; Bokemeyer Carsten; Kröger Nicolaus
Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation.
Blood 2007;109(3):1103-12.
2007: Zippelius Alfred; Gati Asma; Bartnick Tammo; Walton Senta; Odermatt Bernhard; Jaeger Elke; Dummer Reinhold; Urosevic Mirjana; Filonenko Valeriy; Osanai Kazuhiro; Moch Holger; Chen Yao-Tseng; Old Lloyd J; Knuth Alexander; Jaeger Dirk
Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients.
Cancer immunology, immunotherapy : CII 2007;56(2):249-58.
2007: Old Lloyd J
Cancer is a somatic cell pregnancy.
Cancer immunity : a journal of the Academy of Cancer Immunology 2007;7():19.
2007: Silva Wilson A; Gnjatic Sacha; Ritter Erika; Chua Ramon; Cohen Tzeela; Hsu Melinda; Jungbluth Achim A; Altorki Nasser K; Chen Yao-Tseng; Old Lloyd J; Simpson Andrew J G; Caballero Otavia L
PLAC1, a trophoblast-specific cell surface protein, is expressed in a range of human tumors and elicits spontaneous antibody responses.
Cancer immunity : a journal of the Academy of Cancer Immunology 2007;7():18.
2007: Bender Armin; Karbach Julia; Neumann Antje; Jäger Dirk; Al-Batran Salah E; Atmaca Akin; Weidmann Eckhart; Biskamp Melina; Gnjatic Sacha; Pan Linda; Hoffman Eric; Old Lloyd J; Knuth Alexander; Jäger Elke
LUD 00-009: phase 1 study of intensive course immunization with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing cancer.
Cancer immunity : a journal of the Academy of Cancer Immunology 2007;7():16.
2007: Jungbluth Achim A; Silva Wilson A; Iversen Kristin; Frosina Denise; Zaidi Bushra; Coplan Keren; Eastlake-Wade Susannah K; Castelli Sandra B; Spagnoli Giulio C; Old Lloyd J; Vogel Martin
Expression of cancer-testis (CT) antigens in placenta.
Cancer immunity : a journal of the Academy of Cancer Immunology 2007;7():15.
2007: Davis Ian D; Liu Zhanqi; Saunders Wayne; Lee Fook-Thean; Spirkoska Violeta; Hopkins Wendie; Smyth Fiona E; Chong Geoffrey; Papenfuss Anthony T; Chappell Bridget; Poon Aurora; Saunder Timothy H; Hoffman Eric W; Old Lloyd J; Scott Andrew M
A pilot study of monoclonal antibody cG250 and low dose subcutaneous IL-2 in patients with advanced renal cell carcinoma.
Cancer immunity : a journal of the Academy of Cancer Immunology 2007;7():14.
2007: Davis Ian D; Wiseman Gregory A; Lee Fook-Thean; Gansen Denise N; Hopkins Wendie; Papenfuss Anthony T; Liu Zhanqi; Moynihan Timothy J; Croghan Gary A; Adjei Alex A; Hoffman Eric W; Ingle James N; Old Lloyd J; Scott Andrew M
A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma.
Cancer immunity : a journal of the Academy of Cancer Immunology 2007;7():13.
2007: Stevenson Brian J; Iseli Christian; Panji Sumir; Zahn-Zabal Monique; Hide Winston; Old Lloyd J; Simpson Andrew J; Jongeneel C Victor
Rapid evolution of cancer/testis genes on the X chromosome.
BMC genomics 2007;8():129.
2007: Uenaka Akiko; Wada Hisashi; Isobe Midori; Saika Takashi; Tsuji Kazuhide; Sato Eiichi; Sato Shuichiro; Noguchi Yuji; Kawabata Ryohei; Yasuda Takushi; Doki Yuichiro; Kumon Hiromi; Iwatsuki Keiji; Shiku Hiroshi; Monden Morito; Jungbluth Achim A; Ritter Gerd; Murphy Roger; Hoffman Eric; Old Lloyd J; Nakayama Eiichi
T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein.
Cancer immunity : a journal of the Academy of Cancer Immunology 2007;7():9.
2007: Ebel Wolfgang; Routhier Eric L; Foley Brian; Jacob Sara; McDonough Jennifer M; Patel Rina K; Turchin Howard A; Chao Qimin; Kline J Bradford; Old Lloyd J; Phillips Martin D; Nicolaides Nicholas C; Sass Philip M; Grasso Luigi
Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha.
Cancer immunity : a journal of the Academy of Cancer Immunology 2007;7():6.
2007: Odunsi Kunle; Old Lloyd J
Tumor infiltrating lymphocytes: indicators of tumor-related immune responses.
Cancer immunity : a journal of the Academy of Cancer Immunology 2007;7():3.
2007: Nelson Peter T; Zhang Paul J; Spagnoli Giulio C; Tomaszewski John E; Pasha Theresa L; Frosina Denise; Caballero Otavia L; Simpson Andrew J G; Old Lloyd J; Jungbluth Achim A
Cancer/testis (CT) antigens are expressed in fetal ovary.
Cancer immunity : a journal of the Academy of Cancer Immunology 2007;7():1.
2006: Kitano Shigehisa; Kageyama Shinichi; Nagata Yasuhiro; Miyahara Yoshihiro; Hiasa Atsunori; Naota Hiroaki; Okumura Satoshi; Imai Hiroshi; Shiraishi Taizo; Masuya Masahiro; Nishikawa Masakatsu; Sunamoto Junzo; Akiyoshi Kazunari; Kanematsu Takashi; Scott Andrew M; Murphy Roger; Hoffman Eric W; Old Lloyd J; Shiku Hiroshi
HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(24):7397-405.
2006: Sakamoto Junichi; Oriuchi Noboru; Mochiki Erito; Asao Takayuki; Scott Andrew M; Hoffman Eric W; Jungbluth Achim A; Matsui Takanori; Lee F T; Papenfuss Anthony; Kuwano Hiroyuki; Takahashi Toshitada; Endo Keigo; Old Lloyd J
A phase I radioimmunolocalization trial of humanized monoclonal antibody huA33 in patients with gastric carcinoma.
Cancer science 2006;97(11):1248-54.
2006: Tammela Jonathan; Uenaka Akiko; Ono Toshiro; Noguchi Yuji; Jungbluth Achim A; Mhawech-Fauceglia Paulette; Qian Feng; Schneider Sally; Sharma Sameer; Driscoll Deborah; Lele Shashikant; Old Lloyd J; Nakayama Eiichi; Odunsi Kunle
OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer.
International journal of oncology 2006;29(4):903-10.
2006: Godefroy Emmanuelle; Scotto Luigi; Souleimanian Naira E; Ritter Gerd; Old Lloyd J; Jotereau Francine; Valmori Danila; Ayyoub Maha
Identification of two Melan-A CD4+ T cell epitopes presented by frequently expressed MHC class II alleles.
Clinical immunology (Orlando, Fla.) 2006;121(1):54-62.
2006: Sharma Padmanee; Shen Yu; Wen Sijin; Bajorin Dean F; Reuter Victor E; Old Lloyd J; Jungbluth Achim A
Cancer-testis antigens: expression and correlation with survival in human urothelial carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(18):5442-7.
2006: Jäger Elke; Karbach Julia; Gnjatic Sacha; Neumann Antje; Bender Armin; Valmori Danila; Ayyoub Maha; Ritter Erika; Ritter Gerd; Jäger Dirk; Panicali Dennis; Hoffman Eric; Pan Linda; Oettgen Herbert; Old Lloyd J; Knuth Alexander
Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(39):14453-8.
2006: Davis Ian D; Chen Qiyuan; Morris Leone; Quirk Juliet; Stanley Maureen; Tavarnesi Maria L; Parente Phillip; Cavicchiolo Tina; Hopkins Wendie; Jackson Heather; Dimopoulos Nektaria; Tai Tsin Yee; MacGregor Duncan; Browning Judy; Svobodova Suzanne; Caron Dania; Maraskovsky Eugene; Old Lloyd J; Chen Weisan; Cebon Jonathan
Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2006;29(5):499-511.
2006: Ye Sheng-Wei; Wang Yu; Valmori Danila; Ayyoub Maha; Han Yan; Xu Xiao-Lan; Zhao Ai-Lian; Qu Li; Gnjatic Sacha; Ritter Gerd; Old Lloyd J; Gu Jin
Ex-vivo analysis of CD8+ T cells infiltrating colorectal tumors identifies a major effector-memory subset with low perforin content.
Journal of clinical immunology 2006;26(5):447-56.
2006: Bauer Stefan; Adrian Nicole; Fischer Eliane; Kleber Sascha; Stenner Frank; Wadle Andreas; Fadle Natalie; Zoellner Andy; Bernhardt Rita; Knuth Alexander; Old Lloyd J; Renner Christoph
Structure-activity profiles of Ab-derived TNF fusion proteins.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(4):2423-30.
2006: Nakamura Shinichiro; Nouso Kazuhiro; Noguchi Yuji; Higashi Toshihiro; Ono Toshiro; Jungbluth Achim; Chen Yao-Tseng; Old Lloyd J; Nakayama Eiichi; Shiratori Yasushi
Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma.
Journal of gastroenterology and hepatology 2006;21(8):1281-5.
2006: Nishikawa Hiroyoshi; Sato Eiichi; Briones Gabriel; Chen Li-Mei; Matsuo Mitsutoshi; Nagata Yasuhiro; Ritter Gerd; Jäger Elke; Nomura Hideki; Kondo Shigeto; Tawara Isao; Kato Takuma; Shiku Hiroshi; Old Lloyd J; Galán Jorge E; Gnjatic Sacha
In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines.
The Journal of clinical investigation 2006;116(7):1946-54.
2006: Hicks Amy M; Riedlinger Gregory; Willingham Mark C; Alexander-Miller Martha A; Von Kap-Herr C; Pettenati Mark J; Sanders Anne M; Weir Holly M; Du Wei; Kim Joseph; Simpson Andrew J G; Old Lloyd J; Cui Zheng
Transferable anticancer innate immunity in spontaneous regression/complete resistance mice.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(20):7753-8.
2006: Varga Zsuzsanna; Theurillat Jean-Philippe; Filonenko Valeriy; Sasse Bernd; Odermatt Bernhard; Jungbluth Achim A; Chen Yao-Tseng; Old Lloyd J; Knuth Alexander; Jäger Dirk; Moch Holger
Preferential nuclear and cytoplasmic NY-BR-1 protein expression in primary breast cancer and lymph node metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(9):2745-51.
2006: Nishikawa Hiroyoshi; Qian Feng; Tsuji Takemasa; Ritter Gerd; Old Lloyd J; Gnjatic Sacha; Odunsi Kunle
Influence of CD4+CD25+ regulatory T cells on low/high-avidity CD4+ T cells following peptide vaccination.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(10):6340-6.
2006: Jackson Heather; Dimopoulos Nektaria; Mifsud Nicole A; Tai Tsin Yee; Chen Qiyuan; Svobodova Suzanne; Browning Judy; Luescher Immanuel; Stockert Lisa; Old Lloyd J; Davis Ian D; Cebon Jonathan; Chen Weisan
Striking immunodominance hierarchy of naturally occurring CD8+ and CD4+ T cell responses to tumor antigen NY-ESO-1.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(10):5908-17.
2006: Chen Yao-Tseng; Iseli Christian; Venditti Charis A; Old Lloyd J; Simpson Andrew J G; Jongeneel C Victor
Identification of a new cancer/testis gene family, CT47, among expressed multicopy genes on the human X chromosome.
Genes, chromosomes & cancer 2006;45(4):392-400.
2006: Hasegawa Kosei; Noguchi Yuji; Koizumi Fumihito; Uenaka Akiko; Tanaka Motoyuki; Shimono Michihide; Nakamura Hideo; Shiku Hiroshi; Gnjatic Sacha; Murphy Roger; Hiramatsu Yuji; Old Lloyd J; Nakayama Eiichi
In vitro stimulation of CD8 and CD4 T cells by dendritic cells loaded with a complex of cholesterol-bearing hydrophobized pullulan and NY-ESO-1 protein: Identification of a new HLA-DR15-binding CD4 T-cell epitope.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(6):1921-7.
2006: Ayyoub Maha; Souleimanian Naira E; Godefroy Emmanuelle; Scotto Luigi; Hesdorffer Charles S; Old Lloyd J; Valmori Danila
A phenotype based approach for the immune monitoring of NY-ESO-1-specific CD4+ T cell responses in cancer patients.
Clinical immunology (Orlando, Fla.) 2006;118(2-3):188-94.
2006: Karbach Julia; Pauligk Claudia; Bender Armin; Gnjatic Sacha; Franzmann Kerstin; Wahle Claudia; Jäger Dirk; Knuth Alexander; Old Lloyd J; Jäger Elke
Identification of new NY-ESO-1 epitopes recognized by CD4+ T cells and presented by HLA-DQ B1 03011.
International journal of cancer. Journal international du cancer 2006;118(3):668-74.
2006: Valmori Danila; Qian Feng; Ayyoub Maha; Renner Christoph; Merlo Andrea; Gnjatic Sacha; Stockert Elisabeth; Driscoll Deborah; Lele Shashikant; Old Lloyd J; Odunsi Kunle
Expression of synovial sarcoma X (SSX) antigens in epithelial ovarian cancer and identification of SSX-4 epitopes recognized by CD4+ T cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(2):398-404.
2006: Wang Xiaosong; Zhao Haitao; Xu Qingwen; Jin Weibo; Liu Changning; Zhang Huagang; Huang Zhibin; Zhang Xinyu; Zhang Yu; Xin Dianqi; Simpson Andrew J G; Old Lloyd J; Na Yanqun; Zhao Yi; Chen Weifeng
HPtaa database-potential target genes for clinical diagnosis and immunotherapy of human carcinoma.
Nucleic acids research 2006;34(Database issue):D607-12.
2006: Cho Hearn J; Caballero Otavia L; Gnjatic Sacha; Andrade Valéria C C; Colleoni Gisele W; Vettore Andre L; Outtz Hasina H; Fortunato Sheila; Altorki Nasser; Ferrera Cathy A; Chua Ramon; Jungbluth Achim A; Chen Yao-Tseng; Old Lloyd J; Simpson Andrew J G
Physical interaction of two cancer-testis antigens, MAGE-C1 (CT7) and NY-ESO-1 (CT6).
Cancer immunity : a journal of the Academy of Cancer Immunology 2006;6():12.
2006: Hicks Amy M; Willingham Mark C; Du Wei; Pang Changlee S; Old Lloyd J; Cui Zheng
Effector mechanisms of the anti-cancer immune responses of macrophages in SR/CR mice.
Cancer immunity : a journal of the Academy of Cancer Immunology 2006;6():11.
2006: Gnjatic Sacha; Nishikawa Hiroyoshi; Jungbluth Achim A; Güre Ali O; Ritter Gerd; Jäger Elke; Knuth Alexander; Chen Yao-Tseng; Old Lloyd J
NY-ESO-1: review of an immunogenic tumor antigen.
Advances in cancer research 2006;95():1-30.
2006: Zhuang Ran; Zhu Yong; Fang Liang; Liu Xue-Song; Tian Ying; Chen Li-Hua; Ouyang Wei-Ming; Xu Xiao-Guang; Jian Jin-Long; Güre Ali O; Fortunato Sheila; Ritter Gerd; Old Lloyd J; Simpson Andrew J G; Chen Yao T; Jin Boquan; Jungbluth Achim A
Generation of monoclonal antibodies to cancer/testis (CT) antigen CT10/MAGE-C2.
Cancer immunity : a journal of the Academy of Cancer Immunology 2006;6():7.
2006: Scanlan Matthew J; Ritter Gerd; Yin Beatrice W T; Williams Clarence; Cohen Leonard S; Coplan Keren A; Fortunato Sheila R; Frosina Denise; Lee Sang-Yull; Murray Anne E; Chua Ramon; Filonenko Valeriy V; Sato Eiichi; Old Lloyd J; Jungbluth Achim A
Glycoprotein A34, a novel target for antibody-based cancer immunotherapy.
Cancer immunity : a journal of the Academy of Cancer Immunology 2006;6():2.
2005: Sato Eiichi; Olson Sara H; Ahn Jiyoung; Bundy Brian; Nishikawa Hiroyoshi; Qian Feng; Jungbluth Achim A; Frosina Denise; Gnjatic Sacha; Ambrosone Christine; Kepner James; Odunsi Tosin; Ritter Gerd; Lele Shashikant; Chen Yao-Tseng; Ohtani Haruo; Old Lloyd J; Odunsi Kunle
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(51):18538-43.
2005: Gure Ali O; Chua Ramon; Williamson Barbara; Gonen Mithat; Ferrera Cathy A; Gnjatic Sacha; Ritter Gerd; Simpson Andrew J G; Chen Yao-T; Old Lloyd J; Altorki Nasser K
Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(22):8055-62.
2005: Valmori Danila; Souleimanian Naira E; Hesdorffer Charles S; Old Lloyd J; Ayyoub Maha
Quantitative and qualitative assessment of circulating NY-ESO-1 specific CD4+ T cells in cancer-free individuals.
Clinical immunology (Orlando, Fla.) 2005;117(2):161-7.
2005: Nishikawa Hiroyoshi; Kato Takuma; Tawara Isao; Ikeda Hiroaki; Kuribayashi Kagemasa; Allen Paul M; Schreiber Robert D; Old Lloyd J; Shiku Hiroshi
IFN-gamma controls the generation/activation of CD4+ CD25+ regulatory T cells in antitumor immune response.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(7):4433-40.
2005: Sharma Sameer; Qian Feng; Keitz Bernadette; Driscoll Deborah; Scanlan Mathew J; Skipper Jonathan; Rodabaugh Kerry; Lele Shashikant; Old Lloyd J; Odunsi Kunle
A-kinase anchoring protein 3 messenger RNA expression correlates with poor prognosis in epithelial ovarian cancer.
Gynecologic oncology 2005;99(1):183-8.
2005: Valmori Danila; Souleimanian Naira E; Hesdorffer Charles S; Ritter Gerd; Old Lloyd J; Ayyoub Maha
Identification of B cell epitopes recognized by antibodies specific for the tumor antigen NY-ESO-1 in cancer patients with spontaneous immune responses.
Clinical immunology (Orlando, Fla.) 2005;117(1):24-30.
2005: Wadle Andreas; Mischo Axel; Imig Jochen; Wüllner Beate; Hensel Dan; Wätzig Kristin; Neumann Frank; Kubuschok Boris; Schmidt Werner; Old Lloyd J; Pfreundschuh Michael; Renner Christoph
Serological identification of breast cancer-related antigens from a Saccharomyces cerevisiae surface display library.
International journal of cancer. Journal international du cancer 2005;117(1):104-13.
2005: Perera Rushika M; Narita Yoshitaka; Furnari Frank B; Gan Hui K; Murone Carmel; Ahlkvist Marika; Luwor Rodney B; Burgess Antony W; Stockert Elisabeth; Jungbluth Achim A; Old Lloyd J; Cavenee Webster K; Scott Andrew M; Johns Terrance G
Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(17):6390-9.
2005: Simpson Andrew J G; Caballero Otavia L; Jungbluth Achim; Chen Yao-Tseng; Old Lloyd J
Cancer/testis antigens, gametogenesis and cancer.
Nature reviews. Cancer 2005;5(8):615-25.
2005: Nishikawa Hiroyoshi; Jäger Elke; Ritter Gerd; Old Lloyd J; Gnjatic Sacha
CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients.
Blood 2005;106(3):1008-11.
2005: Chong Geoffrey; Lee Fook Thean; Hopkins Wendie; Tebbutt Niall; Cebon Jonathan S; Mountain Angela J; Chappell Bridget; Papenfuss Anthony; Schleyer Paul; U Paul; Murphy Roger; Wirth Veronika; Smyth Fiona E; Potasz Nicole; Poon Aurora; Davis Ian D; Saunder Tim; O'keefe Graeme J; Burgess Antony W; Hoffman Eric W; Old Lloyd J; Scott Andrew M
Phase I trial of 131I-huA33 in patients with advanced colorectal carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13):4818-26.
2005: Scott Andrew M; Lee Fook-Thean; Jones Robert; Hopkins Wendie; MacGregor Duncan; Cebon Jonathan S; Hannah Anthony; Chong Geoffrey; U Paul; Papenfuss Anthony; Rigopoulos Angela; Sturrock Susan; Murphy Roger; Wirth Veronika; Murone Carmel; Smyth Fiona E; Knight Simon; Welt Sydney; Ritter Gerd; Richards Elizabeth; Nice Edouard C; Burgess Antony W; Old Lloyd J
A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptake.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13):4810-7.
2005: Jungbluth Achim A; Ely Scott; DiLiberto Maurizio; Niesvizky Ruben; Williamson Barbara; Frosina Denise; Chen Yao-Tseng; Bhardwaj Nina; Chen-Kiang Selina; Old Lloyd J; Cho Hearn Jay
The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation.
Blood 2005;106(1):167-74.
2005: Nishikawa Hiroyoshi; Kato Takuma; Tawara Isao; Takemitsu Tetsushi; Saito Kanako; Wang Linan; Ikarashi Yoshinori; Wakasugi Hiro; Nakayama Toshinori; Taniguchi Masaru; Kuribayashi Kagemasa; Old Lloyd J; Shiku Hiroshi
Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(26):9253-7.
2005: Vural Burcak; Chen Lin-Chi; Saip Pinar; Chen Yao-Tseng; Ustuner Zeki; Gonen Mithat; Simpson Andrew J G; Old Lloyd J; Ozbek Ugur; Gure Ali O
Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters.
Cancer 2005;103(12):2575-83.
2005: Chen Yao-Tseng; Scanlan Matthew J; Venditti Charis A; Chua Ramon; Theiler Gregory; Stevenson Brian J; Iseli Christian; Gure Ali O; Vasicek Tom; Strausberg Robert L; Jongeneel C Victor; Old Lloyd J; Simpson Andrew J G
Identification of cancer/testis-antigen genes by massively parallel signature sequencing.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(22):7940-5.
2005: Johns Terrance G; Mellman Ira; Cartwright Glenn A; Ritter Gerd; Old Lloyd J; Burgess Antony W; Scott Andrew M
The antitumor monoclonal antibody 806 recognizes a high-mannose form of the EGF receptor that reaches the cell surface when cells over-express the receptor.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(7):780-2.
2005: Dunn Gavin P; Sheehan Kathleen C F; Old Lloyd J; Schreiber Robert D
IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expression.
Cancer research 2005;65(8):3447-53.
2005: Ayyoub Maha; Merlo Andrea; Hesdorffer Charles S; Rimoldi Donata; Speiser Daniel; Cerottini Jean-Charles; Chen Yao-Tseng; Old Lloyd J; Stevanovic Stefan; Valmori Danila
CD4+ T cell responses to SSX-4 in melanoma patients.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(8):5092-9.
2005: Panousis C; Rayzman V M; Johns T G; Renner C; Liu Z; Cartwright G; Lee F-T; Wang D; Gan H; Cao D; Kypridis A; Smyth F E; Brechbiel M W; Burgess A W; Old L J; Scott A M
Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR.
British journal of cancer 2005;92(6):1069-77.
2005: Nishikawa Hiroyoshi; Kato Takuma; Tawara Isao; Saito Kanako; Ikeda Hiroaki; Kuribayashi Kagemasa; Allen Paul M; Schreiber Robert D; Sakaguchi Shimon; Old Lloyd J; Shiku Hiroshi
Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells.
The Journal of experimental medicine 2005;201(5):681-6.
2005: Scott Andrew M; Liu Zhanqi; Murone Carmel; Johns Terrance G; MacGregor Duncan; Smyth Fiona E; Lee Fook-Thean; Cebon Jonathan; Davis Ian D; Hopkins Wendie; Mountain Angela J; Rigopoulos Angela; Hanai Nobuo; Old Lloyd J
Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma.
Cancer immunity : a journal of the Academy of Cancer Immunology 2005;5():3.
2005: Ayyoub Maha; Merlo Andrea; Hesdorffer Charles S; Speiser Daniel; Rimoldi Donata; Cerottini Jean-Charles; Ritter Gerd; Chen Yao-Tseng; Old Lloyd J; Stevanovic Stefan; Valmori Danila
Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2.
Clinical immunology (Orlando, Fla.) 2005;114(1):70-8.
2005: Sato Shuichiro; Noguchi Yuji; Wada Hisashi; Fujita Shoichiro; Nakamura Shinichiro; Tanaka Ryo; Nakada Tetsuya; Hasegawa Kosei; Nakagawa Kazuhiko; Koizumi Fumihito; Ono Toshiro; Nouso Kazuhiro; Jungbluth Achim; Chen Yao-Tseng; Old Lloyd J; Shiratori Yasushi; Nakayama Eiichi
Quantitative real-time RT-PCR analysis of NY-ESO-1 and LAGE-1a mRNA expression in normal tissues and tumors, and correlation of the protein expression with the mRNA copy number.
International journal of oncology 2005;26(1):57-63.
2005: Jäger Dirk; Karbach Julia; Pauligk Claudia; Seil Inka; Frei Claudia; Chen Yao-Tseng; Old Lloyd J; Knuth Alexander; Jäger Elke
Humoral and cellular immune responses against the breast cancer antigen NY-BR-1: definition of two HLA-A2 restricted peptide epitopes.
Cancer immunity : a journal of the Academy of Cancer Immunology 2005;5():11.
2005: Chen Yao-Tseng; Venditti Charis A; Theiler Gregory; Stevenson Brian J; Iseli Christian; Gure Ali O; Jongeneel C Victor; Old Lloyd J; Simpson Andrew J G
Identification of CT46/HORMAD1, an immunogenic cancer/testis antigen encoding a putative meiosis-related protein.
Cancer immunity : a journal of the Academy of Cancer Immunology 2005;5():9.
2005: Murphy R; Green S; Ritter G; Cohen L; Ryan D; Woods W; Rubira M; Cebon J; Davis I D; Sjolander A; Kypridis A; Kalnins H; McNamara M; Moloney M B; Ackland J; Cartwright G; Rood J; Dumsday G; Healey K; Maher D; Maraskovsky E; Chen Y T; Hoffman E W; Old L J; Scott A M
Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions.
Preparative biochemistry & biotechnology 2005;35(2):119-34.
2004: Vaughan Hilary A; Svobodova Suzanne; Macgregor Duncan; Sturrock Sue; Jungbluth Achim A; Browning Judy; Davis Ian D; Parente Philip; Chen Yao-Tseng; Stockert Elisabeth; St Clair Fiona; Old Lloyd J; Cebon Jonathan
Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8396-404.
2004: Huarte Eduardo; Karbach Julia; Gnjatic Sacha; Bender Armin; Jäger Dirk; Arand Michael; Atanackovic Djordje; Skipper Jonathan; Ritter Gerd; Chen Yao-Tseng; Old Lloyd J; Knuth Alexander; Jäger Elke
HLA-DP4 expression and immunity to NY-ESO-1: correlation and characterization of cytotoxic CD4+ CD25- CD8- T cell clones.
Cancer immunity : a journal of the Academy of Cancer Immunology 2004;4():15.
2004: Campagnolo Christine; Meyers Katherine J; Ryan Thomas; Atkinson Robert C; Chen Yao-Tseng; Scanlan Matt J; Ritter Gerd; Old Lloyd J; Batt Carl A
Real-Time, label-free monitoring of tumor antigen and serum antibody interactions.
Journal of biochemical and biophysical methods 2004;61(3):283-98.
2004: Lee Sang-Yull; Williamson Barbara; Caballero Otavia L; Chen Yao-Tseng; Scanlan Matthew J; Ritter Gerd; Jongeneel C Victor; Simpson Andrew J G; Old Lloyd J
Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer.
Cancer immunity : a journal of the Academy of Cancer Immunology 2004;4():13.
2004: Qian Feng; Gnjatic Sacha; Jäger Elke; Santiago Darren; Jungbluth Achim; Grande Cathy; Schneider Sally; Keitz Bernadette; Driscoll Deborah; Ritter Gerd; Lele Shashikant; Sood Ashwani; Old Lloyd J; Odunsi Kunle
Th1/Th2 CD4+ T cell responses against NY-ESO-1 in HLA-DPB1*0401/0402 patients with epithelial ovarian cancer.
Cancer immunity : a journal of the Academy of Cancer Immunology 2004;4():12.
2004: Skipper Jonathan; Hoffman Eric W; O'Donnell-Tormey Jill; Old Lloyd J
Translation of cancer immunotherapies.
Nature medicine 2004;10(11):1154-5; author reply 1155.
2004: Wang Yu; Wu Xiao-Jiang; Zhao Ai-Lian; Yuan Yan-Hua; Chen Yao-Tseng; Jungbluth Achim A; Gnjatic Sacha; Santiago Darren; Ritter Gerd; Chen Wei-Feng; Old Lloyd J; Ji Jia-Fu
Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancer.
Cancer immunity : a journal of the Academy of Cancer Immunology 2004;4():11.
2004: Shang Xiao-Ying; Chen Hong-Song; Zhang Hua-Gang; Pang Xue-Wen; Qiao Huan; Peng Ji-Run; Qin Li-Ling; Fei Ran; Mei Ming-Hui; Leng Xi-Sheng; Gnjatic Sacha; Ritter Gerd; Simpson Andrew J G; Old Lloyd J; Chen Wei-Feng
The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(20):6946-55.
2004: Tammela Jonathan; Jungbluth Achim A; Qian Feng; Santiago Darren; Scanlan Matthew J; Keitz Bernadette; Driscoll Deborah; Rodabaugh Kerry; Lele Shashikant; Old Lloyd J; Odunsi Kunle
SCP-1 cancer/testis antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancer.
Cancer immunity : a journal of the Academy of Cancer Immunology 2004;4():10.
2004: Fujita Shoichiro; Wada Hisashi; Jungbluth Achim A; Sato Shuichiro; Nakata Tetsuya; Noguchi Yuji; Doki Yuichiro; Yasui Masayoshi; Sugita Yurika; Yasuda Takushi; Yano Masahiko; Ono Toshiro; Chen Yao-Tseng; Higashiyama Masahiko; Gnjatic Sacha; Old Lloyd J; Nakayama Eiichi; Monden Morito
NY-ESO-1 expression and immunogenicity in esophageal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(19):6551-8.
2004: Matsuo Mitsutoshi; Nagata Yasuhiro; Sato Eiichi; Atanackovic Djordje; Valmori Danila; Chen Yao-Tseng; Ritter Gerd; Mellman Ira; Old Lloyd J; Gnjatic Sacha
IFN-gamma enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturation.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(40):14467-72.
2004: Held Gerhard; Matsuo Mitsutoshi; Epel Malka; Gnjatic Sacha; Ritter Gerd; Lee Sang Yull; Tai Tsin Yee; Cohen Cyril J; Old Lloyd J; Pfreundschuh Michael; Reiter Yoram; Hoogenboom Hennie R; Renner Christoph
Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragments.
European journal of immunology 2004;34(10):2919-29.
2004: Damasceno Leonardo M; Pla Itzcoatl; Chang Hyun-Joo; Cohen Leonard; Ritter Gerd; Old Lloyd J; Batt Carl A
An optimized fermentation process for high-level production of a single-chain Fv antibody fragment in Pichia pastoris.
Protein expression and purification 2004;37(1):18-26.
2004: Jackson Heather M; Dimopoulos Nektaria; Chen Qiyuan; Luke Tina; Yee Tai Tsin; Maraskovsky Eugene; Old Lloyd J; Davis Ian D; Cebon Jonathan; Chen Weisan
A robust human T-cell culture method suitable for monitoring CD8+ and CD4+ T-cell responses from cancer clinical trial samples.
Journal of immunological methods 2004;291(1-2):51-62.
2004: Dunn Gavin P; Old Lloyd J; Schreiber Robert D
The immunobiology of cancer immunosurveillance and immunoediting.
Immunity 2004;21(2):137-48.
2004: Divgi Chaitanya R; O'Donoghue Joseph A; Welt Sydney; O'Neel Jayne; Finn Ron; Motzer Robert J; Jungbluth Achim; Hoffman Eric; Ritter Gerd; Larson Steve M; Old Lloyd J
Phase I clinical trial with fractionated radioimmunotherapy using 131I-labeled chimeric G250 in metastatic renal cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(8):1412-21.
2004: Vaughan Hilary A; St Clair Fiona; Scanlan Matthew J; Chen Yao-Tsen; Maraskovsky Eugene; Sizeland Andrew; Old Lloyd J; Cebon Jonathan
The humoral immune response to head and neck cancer antigens as defined by the serological analysis of tumor antigens by recombinant cDNA expression cloning.
Cancer immunity : a journal of the Academy of Cancer Immunology 2004;4():5.
2004: Davis Ian D; Chen Weisan; Jackson Heather; Parente Phillip; Shackleton Mark; Hopkins Wendie; Chen Qiyuan; Dimopoulos Nektaria; Luke Tina; Murphy Roger; Scott Andrew M; Maraskovsky Eugene; McArthur Grant; MacGregor Duncan; Sturrock Sue; Tai Tsin Yee; Green Simon; Cuthbertson Andrew; Maher Darryl; Miloradovic Lena; Mitchell Susan V; Ritter Gerd; Jungbluth Achim A; Chen Yao-Tseng; Gnjatic Sacha; Hoffman Eric W; Old Lloyd J; Cebon Jonathan S
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(29):10697-702.
2004: Johns Terrance G; Adams Timothy E; Cochran Jennifer R; Hall Nathan E; Hoyne Peter A; Olsen Mark J; Kim Yong-Sung; Rothacker Julie; Nice Edouard C; Walker Francesca; Ritter Gerd; Jungbluth Achim A; Old Lloyd J; Ward Colin W; Burgess Antony W; Wittrup K Dane; Scott Andrew M
Identification of the epitope for the epidermal growth factor receptor-specific monoclonal antibody 806 reveals that it preferentially recognizes an untethered form of the receptor.
The Journal of biological chemistry 2004;279(29):30375-84.
2004: Chen Qiyuan; Jackson Heather; Parente Phillip; Luke Tina; Rizkalla Mark; Tai Tsin Yee; Zhu He-Cheng; Mifsud Nicole A; Dimopoulos Nektaria; Masterman Kelly-Anne; Hopkins Wendie; Goldie Heather; Maraskovsky Eugene; Green Simon; Miloradovic Lena; McCluskey James; Old Lloyd J; Davis Ian D; Cebon Jonathan; Chen Weisan
Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(25):9363-8.
2004: Ayyoub Maha; Hesdorffer Charles S; Metthez Genevieve; Stevanovic Stefan; Ritter Gerd; Chen Yao-Tseng; Old Lloyd J; Speiser Daniel; Cerottini Jean-Charles; Valmori Danila
Identification of an SSX-2 epitope presented by dendritic cells to circulating autologous CD4+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(11):7206-11.
2004: Strausberg Robert L; Simpson Andrew J G; Old Lloyd J; Riggins Gregory J
Oncogenomics and the development of new cancer therapies.
Nature 2004;429(6990):469-74.
2004: Deckert P Markus; Bornmann William G; Ritter Gerd; Williams Clarence; Franke Juergen; Keilholz Ulrich; Thiel Eckhard; Old Lloyd J; Bertino Joseph R; Welt Sydney
Specific tumour localisation of a huA33 antibody--carboxypeptidase A conjugate and activation of methotrexate-phenylalanine.
International journal of oncology 2004;24(5):1289-95.
2004: Ayyoub Maha; Hesdorffer Charles S; Montes Monica; Merlo Andrea; Speiser Daniel; Rimoldi Donata; Cerottini Jean-Charles; Ritter Gerd; Scanlan Matthew; Old Lloyd J; Valmori Danila
An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DR.
The Journal of clinical investigation 2004;113(8):1225-33.
2004: Wang Yu; Liang Zhen; Yuan Yan-hua; Han Yan; Liu Yue-xiang; Liu Nian; Chen Yao-tseng; Ritter Gerd; Old Lloyd J; Zhang Li-jian
[Expression of multiple cancer-testis antigen genes in non-small cell lung cancer treated by chemotherapy prior surgery]
Zhonghua yi xue za zhi 2004;84(6):464-8.
2004: Sugita Yurika; Wada Hisashi; Fujita Shoichiro; Nakata Tetsuya; Sato Shuichiro; Noguchi Yuji; Jungbluth Achim A; Yamaguchi Masae; Chen Yao-Tseng; Stockert Elisabeth; Gnjatic Sacha; Williamson Barbara; Scanlan Matthew J; Ono Toshiro; Sakita Isao; Yasui Masayoshi; Miyoshi Yasuo; Tamaki Yasuhiro; Matsuura Nariaki; Noguchi Shinzaburo; Old Lloyd J; Nakayama Eiichi; Monden Morito
NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors.
Cancer research 2004;64(6):2199-204.
2004: Atanackovic Djordje; Altorki Nasser K; Stockert Elisabeth; Williamson Barbara; Jungbluth Achim A; Ritter Erika; Santiago Darren; Ferrara Cathy A; Matsuo Mitsutoshi; Selvakumar Annamalai; Dupont Bo; Chen Yao-Tseng; Hoffman Eric W; Ritter Gerd; Old Lloyd J; Gnjatic Sacha
Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(5):3289-96.
2004: Scanlan Matthew J; Simpson Andrew J G; Old Lloyd J
The cancer/testis genes: review, standardization, and commentary.
Cancer immunity : a journal of the Academy of Cancer Immunology 2004;4():1.
2004: Dunn Gavin P; Old Lloyd J; Schreiber Robert D
The three Es of cancer immunoediting.
Annual review of immunology 2004;22():329-60.
2003: Old Lloyd J
Cancer vaccines 2003: opening address.
Cancer immunity : a journal of the Academy of Cancer Immunology 2003;3 Suppl 2():1.
2003: Sharma Padmanee; Gnjatic Sacha; Jungbluth Achim A; Williamson Barbara; Herr Harry; Stockert Elisabeth; Dalbagni Guido; Donat S Machele; Reuter Victor E; Santiago Darren; Chen Yao-Tseng; Bajorin Dean F; Old Lloyd J
Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer.
Cancer immunity : a journal of the Academy of Cancer Immunology 2003;3():19.
2003: Johns Terrance G; Luwor Rodney B; Murone Carmel; Walker Francesca; Weinstock Janet; Vitali Angela A; Perera Rushika M; Jungbluth Achim A; Stockert Elisabeth; Old Lloyd J; Nice Edouard C; Burgess Antony W; Scott Andrew M
Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(26):15871-6.
2003: Chen Yao-Tseng; Alpen Birgit; Ono Toshiro; Gure Ali O; Scanlan Matthew A; Biggs William H; Arden Karen; Nakayama Eiichi; Old Lloyd J
Identification and characterization of mouse SSX genes: a multigene family on the X chromosome with restricted cancer/testis expression.
Genomics 2003;82(6):628-36.
2003: Rodolfo Monica; Luksch Roberto; Stockert Elisabeth; Chen Yao-Tseng; Collini Paola; Ranzani Tiziana; Lombardo Claudia; Dalerba Piero; Rivoltini Licia; Arienti Flavio; Fossati-Bellani Franca; Old Lloyd J; Parmiani Giorgio; Castelli Chiara
Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen.
Cancer research 2003;63(20):6948-55.
2003: Ayyoub Maha; Brehm Michelle; Metthez Geneviève; Talbot Susan; Dutoit Valerie; Taub Robert N; Keohan Mary-Louise; Gure Ali O; Chen Yao-Tseng; Williamson Barbara; Jungbluth Achim A; Old Lloyd J; Hesdorffer Charles S; Valmori Danila
SSX antigens as tumor vaccine targets in human sarcoma.
Cancer immunity : a journal of the Academy of Cancer Immunology 2003;3():13.
2003: Tajima Kouhei; Obata Yuichi; Tamaki Hiromi; Yoshida Masahiro; Chen Yao-Tseng; Scanlan Matthew J; Old Lloyd J; Kuwano Hiroyuki; Takahashi Takashi; Takahashi Toshitada; Mitsudomi Tetsuya
Expression of cancer/testis (CT) antigens in lung cancer.
Lung cancer (Amsterdam, Netherlands) 2003;42(1):23-33.
2003: Odunsi Kunle; Jungbluth Achim A; Stockert Elisabeth; Qian Feng; Gnjatic Sacha; Tammela Jonathan; Intengan Marilyn; Beck Amy; Keitz Bernadette; Santiago Darren; Williamson Barbara; Scanlan Matthew J; Ritter Gerd; Chen Yao-Tseng; Driscoll Deborah; Sood Ashwani; Lele Shashikant; Old Lloyd J
NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.
Cancer research 2003;63(18):6076-83.
2003: Nishikawa Hiroyoshi; Kato Takuma; Tanida Koji; Hiasa Atsunori; Tawara Isao; Ikeda Hiroaki; Ikarashi Yoshinori; Wakasugi Hiro; Kronenberg Mitchell; Nakayama Toshinori; Taniguchi Masaru; Kuribayashi Kagemasa; Old Lloyd J; Shiku Hiroshi
CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(19):10902-6.
2003: Oosterwijk Egbert; Divgi Chaitanya R; Brouwers Adrienne; Boerman Otto C; Larson Steven M; Mulders Peter; Old Lloyd J
Monoclonal antibody-based therapy for renal cell carcinoma.
The Urologic clinics of North America 2003;30(3):623-31.
2003: Tahtis Kiki; Lee Fook-Thean; Wheatley Jennifer M; Garin-Chesa Pilar; Park John E; Smyth Fiona E; Obata Yuichi; Stockert Elisabeth; Hall Cathrine M; Old Lloyd J; Rettig Wolfgang J; Scott Andrew M
Expression and targeting of human fibroblast activation protein in a human skin/severe combined immunodeficient mouse breast cancer xenograft model.
Molecular cancer therapeutics 2003;2(8):729-37.
2003: Atanackovic Djordje; Matsuo Mitsutoshi; Ritter Erika; Mazzara Gail; Ritter Gerd; Jäger Elke; Knuth Alexander; Old Lloyd J; Gnjatic Sacha
Monitoring CD4+ T cell responses against viral and tumor antigens using T cells as novel target APC.
Journal of immunological methods 2003;278(1-2):57-66.
2003: Nakada Tetsuya; Noguchi Yuji; Satoh Shuichiro; Ono Toshiro; Saika Takashi; Kurashige Takushi; Gnjatic Sacha; Ritter Gerd; Chen Yao-Tseng; Stockert Elisabeth; Nasu Yasutomo; Tsushima Tomoyasu; Kumon Hiromi; Old Lloyd J; Nakayama Eiichi
NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer.
Cancer immunity : a journal of the Academy of Cancer Immunology 2003;3():10.
2003: Gnjatic Sacha; Atanackovic Djordje; Jäger Elke; Matsuo Mitsutoshi; Selvakumar Annamalai; Altorki Nasser K; Maki Robert G; Dupont Bo; Ritter Gerd; Chen Yao-Tseng; Knuth Alexander; Old Lloyd J
Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(15):8862-7.
2003: Mischo Axel; Wadle Andreas; Wätzig Kristin; Jäger Dirk; Stockert Elisabeth; Santiago Darren; Ritter Gerd; Regitz Evi; Jäger Elke; Knuth Alex; Old Lloyd; Pfreundschuh Michael; Renner Christoph
Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients.
Cancer immunity : a journal of the Academy of Cancer Immunology 2003;3():5.
2003: Scott Andrew M; Wiseman Greg; Welt Sydney; Adjei Alex; Lee Fook-Thean; Hopkins Wendie; Divgi Chaitan R; Hanson Lorelei H; Mitchell Paul; Gansen Denise N; Larson Steven M; Ingle James N; Hoffman Eric W; Tanswell Paul; Ritter Gerd; Cohen Leonard S; Bette Peter; Arvay Lisa; Amelsberg Andree; Vlock Dan; Rettig Wolfgang J; Old Lloyd J
A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(5):1639-47.
2003: Welt Sydney; Ritter Gerd; Williams Clarence; Cohen Leonard S; Jungbluth Achim; Richards Elizabeth A; Old Lloyd J; Kemeny Nancy E
Preliminary report of a phase I study of combination chemotherapy and humanized A33 antibody immunotherapy in patients with advanced colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(4):1347-53.
2003: Welt Sydney; Ritter Gerd; Williams Clarence; Cohen Leonard S; John Mary; Jungbluth Achim; Richards Elizabeth A; Old Lloyd J; Kemeny Nancy E
Phase I study of anticolon cancer humanized antibody A33.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(4):1338-46.
2003: Deckert P M; Renner C; Cohen L S; Jungbluth A; Ritter G; Bertino J R; Old L J; Welt S
A33scFv-cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapy.
British journal of cancer 2003;88(6):937-9.
2003: Lee Sang-Yull; Obata Yuichi; Yoshida Masahiro; Stockert Elisabeth; Williamson Barbara; Jungbluth Achim A; Chen Yao-Tseng; Old Lloyd J; Scanlan Matthew J
Immunomic analysis of human sarcoma.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(5):2651-6.
2003: Old Lloyd J
Cancer Vaccine Collaborative 2002: opening address.
Cancer immunity : a journal of the Academy of Cancer Immunology 2003;3 Suppl 1():1.
2003: Gnjatic Sacha; Atanackovic Djordje; Matsuo Mitsutoshi; Jäger Elke; Lee Sang Yull; Valmori Danila; Chen Yao-Tseng; Ritter Gerd; Knuth Alexander; Old Lloyd J
Cross-presentation of HLA class I epitopes from exogenous NY-ESO-1 polypeptides by nonprofessional APCs.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(3):1191-6.
2003: Jungbluth Achim A; Stockert Elisabeth; Huang H J Su; Collins Vincent P; Coplan Keren; Iversen Kristin; Kolb Denise; Johns Terrance J; Scott Andrew M; Gullick William J; Ritter Gerd; Cohen Leonard; Scanlan Matthew J; Cavenee Webster K; Old Lloyd J;
A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(2):639-44.
2003: Oosterwijk Egbert; Brouwers Adrienne; Boerman Otto C; Larson Steven M; Old Lloyd J; Mulders Peter; Divgi Chaitanya R
Monoclonal antibody therapy of kidney cancer.
Cancer treatment and research 2003;116():199-212.
2002: Dutoit Valérie; Taub Robert N; Papadopoulos Kyriakos P; Talbot Susan; Keohan Mary-Louise; Brehm Michelle; Gnjatic Sacha; Harris Paul E; Bisikirska Brygida; Guillaume Philippe; Cerottini Jean-Charles; Hesdorffer Charles S; Old Lloyd J; Valmori Danila
Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting.
The Journal of clinical investigation 2002;110(12):1813-22.
2002: Dunn Gavin P; Bruce Allen T; Ikeda Hiroaki; Old Lloyd J; Schreiber Robert D
Cancer immunoediting: from immunosurveillance to tumor escape.
Nature immunology 2002;3(11):991-8.
2002: Liu Zhanqi; Lee Fook-Thean; Hanai Nobuo; Smyth Fiona E; Burgess Antony W; Old Lloyd J; Scott Andrew M
Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871.
Cancer immunity : a journal of the Academy of Cancer Immunology 2002;2():13.
2002: Koroleva Ekaterina P; Lagarkova Maria A; Mesheryakov Andrey A; Scanlan Matthew J; Old Lloyd J; Nedospasov Sergei A; Kuprash Dmitry V
Serological identification of antigens associated with renal cell carcinoma.
Russian journal of immunology : RJI : official journal of Russian Society of Immunology 2002;7(3):229-38.
2002: Scanlan Matthew J; Gure Ali O; Jungbluth Achim A; Old Lloyd J; Chen Yao-Tseng
Cancer/testis antigens: an expanding family of targets for cancer immunotherapy.
Immunological reviews 2002;188():22-32.
2002: Güre Ali O; Wei Isaac J; Old Lloyd J; Chen Yao-Tseng
The SSX gene family: characterization of 9 complete genes.
International journal of cancer. Journal international du cancer 2002;101(5):448-53.
2002: Jäger Elke; Karbach Julia; Gnjatic Sacha; Jäger Dirk; Maeurer Markus; Atmaca Akin; Arand Michael; Skipper Jonathan; Stockert Elisabeth; Chen Yao-Tseng; Old Lloyd J; Knuth Alexander
Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51.
Cancer immunity : a journal of the Academy of Cancer Immunology 2002;2():12.
2002: Alpen Birgit; Güre Ali O; Scanlan Matthew J; Old Lloyd J; Chen Yao-Tseng
A new member of the NY-ESO-1 gene family is ubiquitously expressed in somatic tissues and evolutionarily conserved.
Gene 2002;297(1-2):141-9.
2002: Gnjatic Sacha; Jäger Elke; Chen Weisan; Altorki Nasser K; Matsuo Mitsutoshi; Lee Sang-Yull; Chen Qiyuan; Nagata Yasuhiro; Atanackovic Djordje; Chen Yao-Tseng; Ritter Gerd; Cebon Jonathan; Knuth Alexander; Old Lloyd J
CD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(18):11813-8.
2002: Jäger Dirk; Stockert Elisabeth; Karbach Julia; Herrlinger Kristina; Atmaca Akin; Arand Michael; Chen Yao-Tseng; Gnjatic Sacha; Old Lloyd J; Knuth Alexander; Jäger Elke
Urine antibody against human cancer antigen NY-ESO-1.
Cancer immunity : a journal of the Academy of Cancer Immunology 2002;2():10.
2002: Nagata Yasuhiro; Ono Satoru; Matsuo Mitsutoshi; Gnjatic Sacha; Valmori Danila; Ritter Gerd; Garrett Wendy; Old Lloyd J; Mellman Ira
Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populations.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(16):10629-34.
2002: Scanlan Matthew J; Welt Sydney; Gordon Claudia M; Chen Yao-Tseng; Gure Ali O; Stockert Elisabeth; Jungbluth Achim A; Ritter Gerd; Jäger Dirk; Jäger Elke; Knuth Alexander; Old Lloyd J
Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets.
Cancer research 2002;62(14):4041-7.
2002: Jäger Dirk; Unkelbach Marc; Frei Claudia; Bert Florian; Scanlan Matthew J; Jäger Elke; Old Lloyd J; Chen Yao-Tseng; Knuth Alexander
Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.
Cancer immunity : a journal of the Academy of Cancer Immunology 2002;2():5.
2002: Forti Stefania; Scanlan Matthew J; Invernizzi Annamaria; Castiglioni Fabio; Pupa Sandro; Agresti Roberto; Fontanelli Rosanna; Morelli Daniele; Old Lloyd J; Pupa Serenella M; Ménard Sylvie
Identification of breast cancer-restricted antigens by antibody screening of SKBR3 cDNA library using a preselected patient's serum.
Breast cancer research and treatment 2002;73(3):245-56.
2002: Jungbluth Achim A; Chen Yao-Tseng; Busam Klaus J; Coplan Keren; Kolb Denise; Iversen Kristin; Williamson Barbara; Van Landeghem Frank K H; Stockert Elisabeth; Old Lloyd J
CT7 (MAGE-C1) antigen expression in normal and neoplastic tissues.
International journal of cancer. Journal international du cancer 2002;99(6):839-45.
2002: Scanlan Matthew J; Gordon Claudia M; Williamson Barbara; Lee Sang-Yull; Chen Yao-Tseng; Stockert Elisabeth; Jungbluth Achim; Ritter Gerd; Jäger Dirk; Jäger Elke; Knuth Alexander; Old Lloyd J
Identification of cancer/testis genes by database mining and mRNA expression analysis.
International journal of cancer. Journal international du cancer 2002;98(4):485-92.
2002: Ikeda Hiroaki; Old Lloyd J; Schreiber Robert D
The roles of IFN gamma in protection against tumor development and cancer immunoediting.
Cytokine & growth factor reviews 2002;13(2):95-109.
2002: Johns Terrance G; Stockert Elisabeth; Ritter Gerd; Jungbluth Achim A; Huang H-J Su; Cavenee Webster K; Smyth Fiona E; Hall Cathrine M; Watson Nadine; Nice Edouard C; Gullick William J; Old Lloyd J; Burgess Antony W; Scott Andrew M
Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene.
International journal of cancer. Journal international du cancer 2002;98(3):398-408.
2002: Antonescu Cristina R; Busam Klaus J; Iversen Kristin; Kolb Denise; Coplan Keren; Spagnoli Giulio C; Ladanyi Marc; Old Lloyd J; Jungbluth Achim A
MAGE antigen expression in monophasic and biphasic synovial sarcoma.
Human pathology 2002;33(2):225-9.
2001: Nishikawa H; Tanida K; Ikeda H; Sakakura M; Miyahara Y; Aota T; Mukai K; Watanabe M; Kuribayashi K; Old L J; Shiku H
Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(25):14571-6.
2001: Jungbluth A A; Antonescu C R; Busam K J; Iversen K; Kolb D; Coplan K; Chen Y T; Stockert E; Ladanyi M; Old L J
Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7.
International journal of cancer. Journal international du cancer 2001;94(2):252-6.
2001: Scott A M; Lee F T; Hopkins W; Cebon J S; Wheatley J M; Liu Z; Smyth F E; Murone C; Sturrock S; MacGregor D; Hanai N; Inoue K; Yamasaki M; Brechbiel M W; Davis I D; Murphy R; Hannah A; Lim-Joon M; Chan T; Chong G; Ritter G; Hoffman E W; Burgess A W; Old L J
Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(19):3976-87.
2001: Ritter G; Cohen L S; Williams C; Richards E C; Old L J; Welt S
Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33.
Cancer research 2001;61(18):6851-9.
2001: Luwor R B; Johns T G; Murone C; Huang H J; Cavenee W K; Ritter G; Old L J; Burgess A W; Scott A M
Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR.
Cancer research 2001;61(14):5355-61.
2001: Mishima K; Johns T G; Luwor R B; Scott A M; Stockert E; Jungbluth A A; Ji X D; Suvarna P; Voland J R; Old L J; Huang H J; Cavenee W K
Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.
Cancer research 2001;61(14):5349-54.
2001: Kurashige T; Noguchi Y; Saika T; Ono T; Nagata Y; Jungbluth A; Ritter G; Chen Y T; Stockert E; Tsushima T; Kumon H; Old L J; Nakayama E
Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade.
Cancer research 2001;61(12):4671-4.
2001: Lee F T; Rigopoulos A; Hall C; Clarke K; Cody S H; Smyth F E; Liu Z; Brechbiel M W; Hanai N; Nice E C; Catimel B; Burgess A W; Welt S; Ritter G; Old L J; Scott A M
Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.
Cancer research 2001;61(11):4474-82.
2001: Jungbluth A A; Chen Y T; Stockert E; Busam K J; Kolb D; Iversen K; Coplan K; Williamson B; Altorki N; Old L J
Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues.
International journal of cancer. Journal international du cancer 2001;92(6):856-60.
2001: Lee F T; Hall C; Rigopoulos A; Zweit J; Pathmaraj K; O'Keefe G J; Smyth F E; Welt S; Old L J; Scott A M
Immuno-PET of human colon xenograft- bearing BALB/c nude mice using 124I-CDR-grafted humanized A33 monoclonal antibody.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(5):764-9.
2001: Shankaran V; Ikeda H; Bruce A T; White J M; Swanson P E; Old L J; Schreiber R D
IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity.
Nature 2001;410(6832):1107-11.
2001: Tahtis K; Lee F T; Smyth F E; Power B E; Renner C; Brechbiel M W; Old L J; Hudson P J; Scott A M
Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(4):1061-72.
2001: Scanlan M J; Gout I; Gordon C M; Williamson B; Stockert E; Gure A O; Jäger D; Chen Y T; Mackay A; O'Hare M J; Old L J
Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression.
Cancer immunity : a journal of the Academy of Cancer Immunology 2001;1():4.
2001: Old L J
Cancer/testis (CT) antigens - a new link between gametogenesis and cancer.
Cancer immunity : a journal of the Academy of Cancer Immunology 2001;1():1.
2001: Jäger D; Stockert E; Güre A O; Scanlan M J; Karbach J; Jäger E; Knuth A; Old L J; Chen Y T
Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library.
Cancer research 2001;61(5):2055-61.
2001: Jungbluth A A; King R; Fisher D E; Iversen K; Coplan K; Kolb D; Williamson B; Chen Y T; Stockert E; Old L J; Busam K J
Immunohistochemical and reverse transcription-polymerase chain reaction expression analysis of tyrosinase and microphthalmia-associated transcription factor in angiomyolipomas.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2001;9(1):29-34.
2001: Ono T; Kurashige T; Harada N; Noguchi Y; Saika T; Niikawa N; Aoe M; Nakamura S; Higashi T; Hiraki A; Wada H; Kumon H; Old L J; Nakayama E
Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(6):3282-7.
2000: Ono T; Sato S; Kimura N; Tanaka M; Shibuya A; Old L J; Nakayama E
Serological analysis of BALB/C methylcholanthrene sarcoma Meth A by SEREX: identification of a cancer/testis antigen.
International journal of cancer. Journal international du cancer 2000;88(6):845-51.
2000: Jäger E; Gnjatic S; Nagata Y; Stockert E; Jäger D; Karbach J; Neumann A; Rieckenberg J; Chen Y T; Ritter G; Hoffman E; Arand M; Old L J; Knuth A
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(22):12198-203.
2000: Gnjatic S; Nagata Y; Jager E; Stockert E; Shankara S; Roberts B L; Mazzara G P; Lee S Y; Dunbar P R; Dupont B; Cerundolo V; Ritter G; Chen Y T; Knuth A; Old L J
Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(20):10917-22.
2000: Clarke K; Lee F T; Brechbiel M W; Smyth F E; Old L J; Scott A M
Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(9):3621-8.
2000: Clarke K; Lee F T; Brechbiel M W; Smyth F E; Old L J; Scott A M
In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice.
Cancer research 2000;60(17):4804-11.
2000: Hanson H L; Donermeyer D L; Ikeda H; White J M; Shankaran V; Old L J; Shiku H; Schreiber R D; Allen P M
Eradication of established tumors by CD8+ T cell adoptive immunotherapy.
Immunity 2000;13(2):265-76.
2000: Jungbluth A A; Stockert E; Chen Y T; Kolb D; Iversen K; Coplan K; Williamson B; Altorki N; Busam K J; Old L J
Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours.
British journal of cancer 2000;83(4):493-7.
2000: Deckert P M; Jungbluth A; Montalto N; Clark M A; Finn R D; Williams C; Richards E C; Panageas K S; Old L J; Welt S
Pharmacokinetics and microdistribution of polyethylene glycol-modified humanized A33 antibody targeting colon cancer xenografts.
International journal of cancer. Journal international du cancer 2000;87(3):382-90.
2000: Jäger D; Stockert E; Jäger E; Güre A O; Scanlan M J; Knuth A; Old L J; Chen Y T
Serological cloning of a melanocyte rab guanosine 5'-triphosphate-binding protein and a chromosome condensation protein from a melanoma complementary DNA library.
Cancer research 2000;60(13):3584-91.
2000: Scott A M; Geleick D; Rubira M; Clarke K; Nice E C; Smyth F E; Stockert E; Richards E C; Carr F J; Harris W J; Armour K L; Rood J; Kypridis A; Kronina V; Murphy R; Lee F T; Liu Z; Kitamura K; Ritter G; Laughton K; Hoffman E; Burgess A W; Old L J
Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors.
Cancer research 2000;60(12):3254-61.
2000: Busam K J; Iversen K; Berwick M; Spagnoli G C; Old L J; Jungbluth A A
Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2000;13(4):459-65.
2000: Jäger E; Nagata Y; Gnjatic S; Wada H; Stockert E; Karbach J; Dunbar P R; Lee S Y; Jungbluth A; Jäger D; Arand M; Ritter G; Cerundolo V; Dupont B; Chen Y T; Old L J; Knuth A
Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(9):4760-5.
2000: Güre A O; Stockert E; Scanlan M J; Keresztes R S; Jäger D; Altorki N K; Old L J; Chen Y T
Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(8):4198-203.
2000: Scanlan M J; Altorki N K; Gure A O; Williamson B; Jungbluth A; Chen Y T; Old L J
Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9.
Cancer letters 2000;150(2):155-64.
2000: Güre A O; Stockert E; Arden K C; Boyer A D; Viars C S; Scanlan M J; Old L J; Chen Y T
CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis.
International journal of cancer. Journal international du cancer 2000;85(5):726-32.
2000: Jungbluth A A; Busam K J; Kolb D; Iversen K; Coplan K; Chen Y T; Spagnoli G C; Old L J
Expression of MAGE-antigens in normal tissues and cancer.
International journal of cancer. Journal international du cancer 2000;85(4):460-5.
2000: Jungbluth A A; Iversen K; Coplan K; Kolb D; Stockert E; Chen Y T; Old L J; Busam K
T311--an anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues.
Pathology, research and practice 2000;196(4):235-42.
1999: Jäger D; Stockert E; Scanlan M J; Güre A O; Jäger E; Knuth A; Old L J; Chen Y T
Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.
Cancer research 1999;59(24):6197-204.
1999: Scanlan M J; Gordan J D; Williamson B; Stockert E; Bander N H; Jongeneel V; Gure A O; Jäger D; Jäger E; Knuth A; Chen Y T; Old L J
Antigens recognized by autologous antibody in patients with renal-cell carcinoma.
International journal of cancer. Journal international du cancer 1999;83(4):456-64.
1999: Jäger E; Stockert E; Zidianakis Z; Chen Y T; Karbach J; Jäger D; Arand M; Ritter G; Old L J; Knuth A
Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events.
International journal of cancer. Journal international du cancer 1999;84(5):506-10.
1999: Jungbluth A A; Iversen K; Coplan K; Williamson B; Chen Y T; Stockert E; Old L J; Busam K J
Expression of melanocyte-associated markers gp-100 and Melan-A/MART-1 in angiomyolipomas. An immunohistochemical and rt-PCR analysis.
Virchows Archiv : an international journal of pathology 1999;434(5):429-35.
1999: Scanlan M J; Williamson B; Jungbluth A; Stockert E; Arden K C; Viars C S; Gure A O; Gordan J D; Chen Y T; Old L J
Isoforms of the human PDZ-73 protein exhibit differential tissue expression.
Biochimica et biophysica acta 1999;1445(1):39-52.
1998: Noguchi Y; Wada H; Marino M W; Old L J
Regulation of IFN-gamma production in granulocyte-macrophage colony-stimulating factor-deficient mice.
European journal of immunology 1998;28(12):3980-8.
1998: Divgi C R; Bander N H; Scott A M; O'Donoghue J A; Sgouros G; Welt S; Finn R D; Morrissey F; Capitelli P; Williams J M; Deland D; Nakhre A; Oosterwijk E; Gulec S; Graham M C; Larson S M; Old L J
Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(11):2729-39.
1998: Rodig S; Kaplan D; Shankaran V; Old L; Schreiber R D
Signaling and signaling dysfunction through the interferon gamma receptor.
European cytokine network 1998;9(3 Suppl):49-53.
1998: Cohen A M; Garin-Chesa P; Hanson M; Weyhrauch K; Kemeny N; Fong Y; Paty P; Welt S; Old L
In vitro detection of occult bone marrow metastases in patients with colorectal cancer hepatic metastases.
Diseases of the colon and rectum 1998;41(9):1112-5.
1998: Catimel B; Scott A M; Lee F T; Hanai N; Ritter G; Welt S; Old L J; Burgess A W; Nice E C
Direct immobilization of gangliosides onto gold-carboxymethyldextran sensor surfaces by hydrophobic interaction: applications to antibody characterization.
Glycobiology 1998;8(9):927-38.
1998: Busam K J; Chen Y T; Old L J; Stockert E; Iversen K; Coplan K A; Rosai J; Barnhill R L; Jungbluth A A
Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
The American journal of surgical pathology 1998;22(8):976-82.
1998: Türeci O; Chen Y T; Sahin U; Güre A O; Zwick C; Villena C; Tsang S; Seitz G; Old L J; Pfreundschuh M
Expression of SSX genes in human tumors.
International journal of cancer. Journal international du cancer 1998;77(1):19-23.
1998: Kaplan D H; Shankaran V; Dighe A S; Stockert E; Aguet M; Old L J; Schreiber R D
Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(13):7556-61.
1998: Chen Y T; Güre A O; Tsang S; Stockert E; Jäger E; Knuth A; Old L J
Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(12):6919-23.
1998: Scanlan M J; Chen Y T; Williamson B; Gure A O; Stockert E; Gordan J D; Türeci O; Sahin U; Pfreundschuh M; Old L J
Characterization of human colon cancer antigens recognized by autologous antibodies.
International journal of cancer. Journal international du cancer 1998;76(5):652-8.
1998: Jungbluth A A; Busam K J; Gerald W L; Stockert E; Coplan K A; Iversen K; MacGregor D P; Old L J; Chen Y T
A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues.
The American journal of surgical pathology 1998;22(5):595-602.
1998: Stockert E; Jäger E; Chen Y T; Scanlan M J; Gout I; Karbach J; Arand M; Knuth A; Old L J
A survey of the humoral immune response of cancer patients to a panel of human tumor antigens.
The Journal of experimental medicine 1998;187(8):1349-54.
1998: Old L J; Chen Y T
New paths in human cancer serology.
The Journal of experimental medicine 1998;187(8):1163-7.
1998: Loh A; Sgouros G; O'Donoghue J A; Deland D; Puri D; Capitelli P; Humm J L; Larson S M; Old L J; Divgi C R
Pharmacokinetic model of iodine-131-G250 antibody in renal cell carcinoma patients.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(3):484-9.
1998: Güre A O; Altorki N K; Stockert E; Scanlan M J; Old L J; Chen Y T
Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3.
Cancer research 1998;58(5):1034-41.
1998: Barendswaard E C; Scott A M; Divgi C R; Williams C; Coplan K; Riedel E; Yao T J; Gansow O A; Finn R D; Larson S M; Old L J; Welt S
Rapid and specific targeting of monoclonal antibody A33 to a colon cancer xenograft in nude mice.
International journal of oncology 1998;12(1):45-53.
1998: Jäger E; Chen Y T; Drijfhout J W; Karbach J; Ringhoffer M; Jäger D; Arand M; Wada H; Noguchi Y; Stockert E; Old L J; Knuth A
Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes.
The Journal of experimental medicine 1998;187(2):265-70.
1998: Liu J; Marino M W; Wong G; Grail D; Dunn A; Bettadapura J; Slavin A J; Old L; Bernard C C
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.
Nature medicine 1998;4(1):78-83.
1998: Busam K J; Iversen K; Coplan K A; Old L J; Stockert E; Chen Y T; McGregor D; Jungbluth A
Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors.
The American journal of surgical pathology 1998;22(1):57-63.
1997: Wada H; Noguchi Y; Marino M W; Dunn A R; Old L J
T cell functions in granulocyte/macrophage colony-stimulating factor deficient mice.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(23):12557-61.
1997: Gure A O; Türeci O; Sahin U; Tsang S; Scanlan M J; Jäger E; Knuth A; Pfreundschuh M; Old L J; Chen Y T
SSX: a multigene family with several members transcribed in normal testis and human cancer.
International journal of cancer. Journal international du cancer 1997;72(6):965-71.
1997: Elkon K B; Liu C C; Gall J G; Trevejo J; Marino M W; Abrahamsen K A; Song X; Zhou J L; Old L J; Crystal R G; Falck-Pedersen E
Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(18):9814-9.
1997: Ritter G; Cohen L S; Nice E C; Catimel B; Burgess A W; Moritz R L; Ji H; Heath J K; White S J; Welt S; Old L J; Simpson R J
Characterization of posttranslational modifications of human A33 antigen, a novel palmitoylated surface glycoprotein of human gastrointestinal epithelium.
Biochemical and biophysical research communications 1997;236(3):682-6.
1997: Marino M W; Dunn A; Grail D; Inglese M; Noguchi Y; Richards E; Jungbluth A; Wada H; Moore M; Williamson B; Basu S; Old L J
Characterization of tumor necrosis factor-deficient mice.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(15):8093-8.
1997: Tschmelitsch J; Barendswaard E; Williams C; Yao T J; Cohen A M; Old L J; Welt S
Enhanced antitumor activity of combination radioimmunotherapy (131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil).
Cancer research 1997;57(11):2181-6.
1997: Ikeda H; Ohta N; Furukawa K; Miyazaki H; Wang L; Kuribayashi K; Old L J; Shiku H
Mutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcoma.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(12):6375-9.
1997: Ji H; Moritz R L; Reid G E; Ritter G; Catimel B; Nice E; Heath J K; White S J; Welt S; Old L J; Burgess A W; Simpson R J
Electrophoretic analysis of the novel antigen for the gastrointestinal-specific monoclonal antibody, A33.
Electrophoresis 1997;18(3-4):614-21.
1997: Chen Y T; Scanlan M J; Sahin U; Türeci O; Gure A O; Tsang S; Williamson B; Stockert E; Pfreundschuh M; Old L J
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(5):1914-8.
1997: Heath J K; White S J; Johnstone C N; Catimel B; Simpson R J; Moritz R L; Tu G F; Ji H; Whitehead R H; Groenen L C; Scott A M; Ritter G; Cohen L; Welt S; Old L J; Nice E C; Burgess A W
The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(2):469-74.
1997: Chen Y T; Boyer A D; Viars C S; Tsang S; Old L J; Arden K C
Genomic cloning and localization of CTAG, a gene encoding an autoimmunogenic cancer-testis antigen NY-ESO-1, to human chromosome Xq28.
Cytogenetics and cell genetics 1997;79(3-4):237-40.
1996: Noguchi Y; Jungbluth A; Richards E C; Old L J
Effect of interleukin 12 on tumor induction by 3-methylcholanthrene.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(21):11798-801.
1996: Catimel B; Ritter G; Welt S; Old L J; Cohen L; Nerrie M A; White S J; Heath J K; Demediuk B; Domagala T; Lee F T; Scott A M; Tu G F; Ji H; Moritz R L; Simpson R J; Burgess A W; Nice E C
Purification and characterization of a novel restricted antigen expressed by normal and transformed human colonic epithelium.
The Journal of biological chemistry 1996;271(41):25664-70.
1996: Daghighian F; Barendswaard E; Welt S; Humm J; Scott A; Willingham M C; McGuffie E; Old L J; Larson S M
Enhancement of radiation dose to the nucleus by vesicular internalization of iodine-125-labeled A33 monoclonal antibody.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(6):1052-7.
1996: Welt S; Scott A M; Divgi C R; Kemeny N E; Finn R D; Daghighian F; Germain J S; Richards E C; Larson S M; Old L J
Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(6):1787-97.
1996: Chen Y T; Stockert E; Jungbluth A; Tsang S; Coplan K A; Scanlan M J; Old L J
Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(12):5915-9.
1996: Ritter G; Fortunato S R; Cohen L; Noguchi Y; Bernard E M; Stockert E; Old L J
Induction of antibodies reactive with GM2 ganglioside after immunization with lipopolysaccharides from Camplyobacter jejuni.
International journal of cancer. Journal international du cancer 1996;66(2):184-90.
1995: Ritter G; Ritter-Boosfeld E; Adluri R; Calves M; Ren S; Yu R K; Oettgen H F; Old L J; Livingston P O
Analysis of the antibody response to immunization with purified O-acetyl GD3 gangliosides in patients with malignant melanoma.
International journal of cancer. Journal international du cancer 1995;62(6):668-72.
1995: Chen Y T; Stockert E; Tsang S; Coplan K A; Old L J
Immunophenotyping of melanomas for tyrosinase: implications for vaccine development.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(18):8125-9.
1995: Brenner P C; Rettig W J; Sanz-Moncasi M P; Reuter V; Aprikian A; Old L J; Fair W R; Garin-Chesa P
TAG-72 expression in primary, metastatic and hormonally treated prostate cancer as defined by monoclonal antibody CC49.
The Journal of urology 1995;153(5):1575-9.
1995: Noguchi Y; Richards E C; Chen Y T; Old L J
Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(6):2219-23.
1995: Kitamura K; Livingston P O; Fortunato S R; Stockert E; Helling F; Ritter G; Oettgen H F; Old L J
Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(7):2805-9.
1995: Mathew S; Scanlan M J; Mohan Raj B K; Murty V V; Garin-Chesa P; Old L J; Rettig W J; Chaganti R S
The gene for fibroblast activation protein alpha (FAP), a putative cell surface-bound serine protease expressed in cancer stroma and wound healing, maps to chromosome band 2q23.
Genomics 1995;25(1):335-7.
1994: Kitamura K; Stockert E; Garin-Chesa P; Welt S; Lloyd K O; Armour K L; Wallace T P; Harris W J; Carr F J; Old L J
Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinants.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(26):12957-61.
1994: Sanz-Moncasi M P; Garin-Chesa P; Stockert E; Jaffe E A; Old L J; Rettig W J
Identification of a high molecular weight endothelial cell surface glycoprotein, endoGlyx-1, in normal and tumor blood vessels.
Laboratory investigation; a journal of technical methods and pathology 1994;71(3):366-73.
1994: Rettig W J; Su S L; Fortunato S R; Scanlan M J; Raj B K; Garin-Chesa P; Healey J H; Old L J
Fibroblast activation protein: purification, epitope mapping and induction by growth factors.
International journal of cancer. Journal international du cancer 1994;58(3):385-92.
1994: Welt S; Divgi C R; Scott A M; Garin-Chesa P; Finn R D; Graham M; Carswell E A; Cohen A; Larson S M; Old L J
Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(6):1193-203.
1994: Scanlan M J; Raj B K; Calvo B; Garin-Chesa P; Sanz-Moncasi M P; Healey J H; Old L J; Rettig W J
Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(12):5657-61.
1994: Caron P C; Jurcic J G; Scott A M; Finn R D; Divgi C R; Graham M C; Jureidini I M; Sgouros G; Tyson D; Old L J
A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicity.
Blood 1994;83(7):1760-8.
1994: Noguchi Y; Chen Y T; Old L J
A mouse mutant p53 product recognized by CD4+ and CD8+ T cells.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(8):3171-5.
1994: Chen Y T; Stockert E; Chen Y; Garin-Chesa P; Rettig W J; van der Bruggen P; Boon T; Old L J
Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(3):1004-8.
1993: Czuczman M S; Straus D J; Divgi C R; Graham M; Garin-Chesa P; Finn R; Myers J; Old L J; Larson S M; Scheinberg D A
Phase I dose-escalation trial of iodine 131-labeled monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(10):2021-9.
1993: Rettig W J; Garin-Chesa P; Healey J H; Su S L; Ozer H L; Schwab M; Albino A P; Old L J
Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin.
Cancer research 1993;53(14):3327-35.
1993: Garin-Chesa P; Campbell I; Saigo P E; Lewis J L; Old L J; Rettig W J
Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein.
The American journal of pathology 1993;142(2):557-67.
1993: Schwartz M A; Lovett D R; Redner A; Finn R D; Graham M C; Divgi C R; Dantis L; Gee T S; Andreeff M; Old L J
Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemias.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(2):294-303.
1992: Rettig W J; Garin-Chesa P; Healey J H; Su S L; Jaffe E A; Old L J
Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(22):10832-6.
1992: O'Boyle K P; Zamore R; Adluri S; Cohen A; Kemeny N; Welt S; Lloyd K O; Oettgen H F; Old L J; Livingston P O
Immunization of colorectal cancer patients with modified ovine submaxillary gland mucin and adjuvants induces IgM and IgG antibodies to sialylated Tn.
Cancer research 1992;52(20):5663-7.
1991: Kalisiak A; Minniti J G; Oosterwijk E; Old L J; Scheinberg D A
Neutral glycosphingolipid expression in B-cell neoplasms.
International journal of cancer. Journal international du cancer 1991;49(6):837-45.
1991: Cote R J; Rosen P P; Lesser M L; Old L J; Osborne M P
Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(10):1749-56.
1991: Oosterwijk E; Kalisiak A; Wakka J C; Scheinberg D A; Old L J
Monoclonal antibodies against Gal alpha 1-4Gal beta 1-4Glc (Pk, CD77) produced with a synthetic glycoconjugate as immunogen: reactivity with carbohydrates, with fresh frozen human tissues and hematopoietic tumors.
International journal of cancer. Journal international du cancer 1991;48(6):848-54.
1991: Ritter G; Boosfeld E; Adluri R; Calves M; Oettgen H F; Old L J; Livingston P
Antibody response to immunization with ganglioside GD3 and GD3 congeners (lactones, amide and gangliosidol) in patients with malignant melanoma.
International journal of cancer. Journal international du cancer 1991;48(3):379-85.
1991: Osborne M P; Wong G Y; Asina S; Old L J; Cote R J; Rosen P P
Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow.
Cancer research 1991;51(10):2706-9.
1991: Kalisiak A; Oosterwijk E; Minniti J G; Old L J; Scheinberg D A
A monoclonal antibody for terminal beta-galactose. Use in analysis of glycosphingolipids.
Glycoconjugate journal 1991;8(1):55-62.
1990: Ritter G; Boosfeld E; Calves M J; Oettgen H F; Old L J; Livingston P O
Antibody response to immunization with purified GD3 ganglioside and GD3 derivatives (lactones, amide and gangliosidol) in the mouse.
Immunobiology 1990;182(1):32-43.
1990: Garin-Chesa P; Old L J; Rettig W J
Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(18):7235-9.
1990: Ebert T; Bander N H; Finstad C L; Ramsawak R D; Old L J
Establishment and characterization of human renal cancer and normal kidney cell lines.
Cancer research 1990;50(17):5531-6.
1990: Scheinberg D A; Straus D J; Yeh S D; Divgi C; Garin-Chesa P; Graham M; Pentlow K; Coit D; Oettgen H F; Old L J
A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expression.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(5):792-803.
1990: Yamaguchi H; Furukawa K; Fortunato S R; Livingston P O; Lloyd K O; Oettgen H F; Old L J
Human monoclonal antibody with dual GM2/GD2 specificity derived from an immunized melanoma patient.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(9):3333-7.
1990: Chen Y T; Rettig W J; Yenamandra A K; Kozak C A; Chaganti R S; Posner J B; Old L J
Cerebellar degeneration-related antigen: a highly conserved neuroectodermal marker mapped to chromosomes X in human and mouse.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(8):3077-81.
1990: Ritter G; Boosfeld E; Markstein E; Yu R K; Ren S L; Stallcup W B; Oettgen H F; Old L J; Livingston P O
Biochemical and serological characteristics of natural 9-O-acetyl GD3 from human melanoma and bovine buttermilk and chemically O-acetylated GD3.
Cancer research 1990;50(5):1403-10.
1989: Bander N H; Finstad C L; Cordon-Cardo C; Ramsawak R D; Vaughan E D; Whitmore W F; Oettgen H F; Melamed M R; Old L J
Analysis of a mouse monoclonal antibody that reacts with a specific region of the human proximal tubule and subsets renal cell carcinomas.
Cancer research 1989;49(23):6774-80.
1989: Livingston P O; Ritter G; Srivastava P; Padavan M; Calves M J; Oettgen H F; Old L J
Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside.
Cancer research 1989;49(24 Pt 1):7045-50.
1989: Xu M; Real F X; Welt S; Schüssler M H; Oettgen H F; Old L J
Expression of TAG-72 in normal colon, transitional mucosa, and colon cancer.
International journal of cancer. Journal international du cancer 1989;44(6):985-9.
1989: Lloyd K O; Old L J
Human monoclonal antibodies to glycolipids and other carbohydrate antigens: dissection of the humoral immune response in cancer patients.
Cancer research 1989;49(13):3445-51.
1989: Scheinberg D A; Tanimoto M; McKenzie S; Strife A; Old L J; Clarkson B D
Monoclonal antibody M195: a diagnostic marker for acute myelogenous leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1989;3(6):440-5.
1989: Tanimoto M; Scheinberg D A; Cordon-Cardo C; Huie D; Clarkson B D; Old L J
Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1989;3(5):339-48.
1989: Osborne M P; Asina S; Wong G Y; Old L J; Cote R J
Immunofluorescent monoclonal antibody detection of breast cancer in bone marrow: sensitivity in a model system.
Cancer research 1989;49(9):2510-3.
1989: Furneaux H M; Dropcho E J; Barbut D; Chen Y T; Rosenblum M K; Old L J; Posner J B
Characterization of a cDNA encoding a 34-kDa Purkinje neuron protein recognized by sera from patients with paraneoplastic cerebellar degeneration.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(8):2873-7.
1989: Srivastava P K; Old L J
Identification of a human homologue of the murine tumor rejection antigen GP96.
Cancer research 1989;49(6):1341-3.
1989: Schadendorf D; Yamaguchi H; Old L J; Srivastava P K
A novel heteromorphic human cell surface alloantigen, gp60, defined by a human monoclonal antibody.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(5):1621-5.
1989: Garin-Chesa P; Beresford H R; Carrato-Mena A; Oettgen H F; Old L J; Melamed M R; Rettig W J
Cell surface molecules of human melanoma. Immunohistochemical analysis of the gp57, GD3, and mel-CSPG antigenic systems.
The American journal of pathology 1989;134(2):295-303.
1989: Furukawa K S; Furukawa K; Real F X; Old L J; Lloyd K O
A unique antigenic epitope of human melanoma is carried on the common melanoma glycoprotein gp95/p97.
The Journal of experimental medicine 1989;169(2):585-90.
1989: Furukawa K; Yamaguchi H; Oettgen H F; Old L J; Lloyd K O
Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies.
Cancer research 1989;49(1):191-6.
1988: Furukawa K; Yamaguchi H; Oettgen H F; Old L J; Lloyd K O
Analysis of the expression of N-glycolylneuraminic acid-containing gangliosides in cells and tissues using two human monoclonal antibodies.
The Journal of biological chemistry 1988;263(34):18507-12.
1988: Bazinet M; Cote R J; Cordon-Cardo C; Myc A; Fair W R; Old L J
Immunohistochemical characterization of two monoclonal antibodies, P25.48 and P25.91, which define a new prostate-specific antigen.
Cancer research 1988;48(23):6938-42.
1988: Vadhan-Raj S; Cordon-Cardo C; Carswell E; Mintzer D; Dantis L; Duteau C; Templeton M A; Oettgen H F; Old L J; Houghton A N
Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(10):1636-48.
1988: Cordon-Cardo C; Reuter V E; Lloyd K O; Sheinfeld J; Fair W R; Old L J; Melamed M R
Blood group-related antigens in human urothelium: enhanced expression of precursor, LeX, and LeY determinants in urothelial carcinoma.
Cancer research 1988;48(14):4113-20.
1988: Schrump D S; Furukawa K; Yamaguchi H; Lloyd K O; Old L J
Recognition of galactosylgloboside by monoclonal antibodies derived from patients with primary lung cancer.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(12):4441-5.
1988: Real F X; Furukawa K S; Mattes M J; Gusik S A; Cordon-Cardo C; Oettgen H F; Old L J; Lloyd K O
Class 1 (unique) tumor antigens of human melanoma: identification of unique and common epitopes on a 90-kDa glycoprotein.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(11):3965-9.
1988: Cote R J; Rosen P P; Hakes T B; Sedira M; Bazinet M; Kinne D W; Old L J; Osborne M P
Monoclonal antibodies detect occult breast carcinoma metastases in the bone marrow of patients with early stage disease.
The American journal of surgical pathology 1988;12(5):333-40.
1988: Klein C E; Ozer H L; Traganos F; Atzpodien J; Oettgen H F; Old L J
A transformation-associated 130-kD cell surface glycoprotein is growth controlled in normal human cells.
The Journal of experimental medicine 1988;167(5):1684-96.
1988: Rettig W J; Grzeschik K H; Yenamandra A K; Garcia E; Old L J
Definition of selectable cell surface markers for human chromosomes and chromosome segments in rodent-human hybrids.
Somatic cell and molecular genetics 1988;14(3):223-31.
1988: Rettig W J; Garin-Chesa P; Beresford H R; Oettgen H F; Melamed M R; Old L J
Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(9):3110-4.
1988: Thomson T M; Real F X; Murakami S; Cordon-Cardo C; Old L J; Houghton A N
Differentiation antigens of melanocytes and melanoma: analysis of melanosome and cell surface markers of human pigmented cells with monoclonal antibodies.
The Journal of investigative dermatology 1988;90(4):459-66.
1988: Chesa P G; Rettig W J; Thomson T M; Old L J; Melamed M R
Immunohistochemical analysis of nerve growth factor receptor expression in normal and malignant human tissues.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1988;36(4):383-9.
1988: Thomson T M; Rettig W J; Chesa P G; Green S H; Mena A C; Old L J
Expression of human nerve growth factor receptor on cells derived from all three germ layers.
Experimental cell research 1988;174(2):533-9.
1988: Rettig W J; Chesa P G; Beresford H R; Melamed M R; Old L J
Definition of an extracellular matrix protein in rostral portions of the human central nervous system.
Brain research 1988;438(1-2):315-22.
1988: Srivastava P K; Kozak C A; Old L J
Chromosomal assignment of the gene encoding the mouse tumor rejection antigen gp96.
Immunogenetics 1988;28(3):205-7.
1987: Mattes M J; Look K; Furukawa K; Pierce V K; Old L J; Lewis J L; Lloyd K O
Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells.
Cancer research 1987;47(24 Pt 1):6741-50.
1987: Mattes M J; Real F X; Furukawa K; Old L J; Lloyd K O
Class 1 (unique) tumor antigens of human melanoma: partial purification and characterization of the FD antigen and analysis of a mouse polyclonal antiserum.
Cancer research 1987;47(24 Pt 1):6614-9.
1987: Klein C E; Cordon-Cardo C; Soehnchen R; Cote R J; Oettgen H F; Eisinger M; Old L J
Changes in cell surface glycoprotein expression during differentiation of human keratinocytes.
The Journal of investigative dermatology 1987;89(5):500-6.
1987: Welt S; Carswell E A; Vogel C W; Oettgen H F; Old L J
Immune and nonimmune effector functions of IgG3 mouse monoclonal antibody R24 detecting the disialoganglioside GD3 on the surface of melanoma cells.
Clinical immunology and immunopathology 1987;45(2):214-29.
1987: Kantor R R; Mattes M J; Lloyd K O; Old L J; Albino A P
Biochemical analysis of two cell surface glycoprotein complexes, very common antigen 1 and very common antigen 2. Relationship to very late activation T cell antigens.
The Journal of biological chemistry 1987;262(31):15158-65.
1987: Kantor R R; Bander N H; Finstad C L; Graf L H; Lloyd K O; Old L J; Albino A P
DNA-mediated gene transfer of a human cell surface 170-kilodalton glycoprotein. Evidence for association with an endogenous murine protein.
The Journal of biological chemistry 1987;262(31):15166-71.
1987: Rettig W J; Nishimura H; Yenamandra A K; Seki T; Obata F; Beresford H R; Old L J; Silver J
Differential expression of the human Thy-1 gene in rodent-human somatic cell hybrids [corrected]
Journal of immunology (Baltimore, Md. : 1950) 1987;138(12):4484-9.
1987: Chesa P G; Rettig W J; Melamed M R; Old L J; Niman H L
Expression of p21ras in normal and malignant human tissues: lack of association with proliferation and malignancy.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(10):3234-8.
1987: Livingston P O; Natoli E J; Calves M J; Stockert E; Oettgen H F; Old L J
Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(9):2911-5.
1987: Yamaguchi H; Furukawa K; Fortunato S R; Livingston P O; Lloyd K O; Oettgen H F; Old L J
Cell-surface antigens of melanoma recognized by human monoclonal antibodies.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(8):2416-20.
1987: Rettig W J; Spengler B A; Chesa P G; Old L J; Biedler J L
Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants.
Cancer research 1987;47(5):1383-9.
1987: Brook J D; Beresford H R; Shaw D J; Old L J; Rettig W J
Localisation on human chromosome 19 of three genes for cell surface antigens defined by monoclonal antibodies.
Cytogenetics and cell genetics 1987;45(3-4):156-62.
1986: Rettig W J; Chesa P G; Beresford H R; Feickert H J; Jennings M T; Cohen J; Oettgen H F; Old L J
Differential expression of cell surface antigens and glial fibrillary acidic protein in human astrocytoma subsets.
Cancer research 1986;46(12 Pt 1):6406-12.
1986: Real F X; Rettig W J; Chesa P G; Melamed M R; Old L J; Mendelsohn J
Expression of epidermal growth factor receptor in human cultured cells and tissues: relationship to cell lineage and stage of differentiation.
Cancer research 1986;46(9):4726-31.
1986: Natoli E J; Livingston P O; Pukel C S; Lloyd K O; Wiegandt H; Szalay J; Oettgen H F; Old L J
A murine monoclonal antibody detecting N-acetyl- and N-glycolyl-GM2: characterization of cell surface reactivity.
Cancer research 1986;46(8):4116-20.
1985: Rettig W J; Dracopoli N C; Chesa P G; Spengler B A; Beresford H R; Davies P; Biedler J L; Old L J
Role of human chromosome 11 in determining surface antigenic phenotype of normal and malignant cells. Somatic cell genetic analysis of eight antigens, including putative human Thy-1.
The Journal of experimental medicine 1985;162(5):1603-19.
1985: Rettig W J; Chesa P G; Jennings M T; Spengler B A; Melamed M R; Oettgen H F; Biedler J L; Old L J
Cell surface antigen of human neuroblastomas is related to nuclear antigen of normal cells.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(20):6894-8.
1985: Houghton A N; Mintzer D; Cordon-Cardo C; Welt S; Fliegel B; Vadhan S; Carswell E; Melamed M R; Oettgen H F; Old L J
Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(4):1242-6.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Lloyd Old

Research Profile (preview)

Chemicals & Drugs

Living Beings

Disorders

Anatomy

Concepts & Ideas

Genes & Molecular Sequences

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Lloyd Old (preview)

All Publications